Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 842 articles:
HTML format
Text format



Single Articles


    July 2018
  1. RUSSO N, Brown RS Jr, Shen NT, Pisa JF, et al
    Hepatology highlights.
    Hepatology. 2018;68:1-3.
    PubMed     Text format    


    June 2018
  2. HUI ST, Kurt Z, Tuominen I, Norheim F, et al
    The Genetic Architecture of Diet-induced Hepatic Fibrosis in Mice.
    Hepatology. 2018 Jun 16. doi: 10.1002/hep.30113.
    PubMed     Text format     Abstract available


  3. HAYASHI S, Khan A, Simons BC, Homan C, et al
    A novel association between core mutations in hepatitis B virus genotype F1b and hepatocellular carcinoma in Alaskan Native People.
    Hepatology. 2018 Jun 12. doi: 10.1002/hep.30111.
    PubMed     Text format     Abstract available


  4. BHUSHAN B, Stoops JW, Mars WM, Orr A, et al
    TCPOBOP-induced hepatomegaly & hepatocyte proliferation is attenuated by combined disruption of MET & EGFR signaling.
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30109.
    PubMed     Text format     Abstract available


  5. CHINO F, Pollis KE, Choi S, Salama JK, et al
    Stereotactic Body Radiation Therapy-induced Abscopal Effect on Hepatocellular Carcinoma after Treatment for Lung Cancer: A Case Report.
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30100.
    PubMed     Text format    


  6. PELLICANO R, Durazzo M
    Upper GI bleeding in cirrhotic patients: Which method to search for Helicobacter pylori infection?
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30108.
    PubMed     Text format    


  7. RUSSO N, Brown RS Jr, Cohen-Mekelburg S, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2018;67:2065-2067.
    PubMed     Text format    


    May 2018
  8. GOEDEKE L, Bates J, Vatner DF, Perry RJ, et al
    Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30097.
    PubMed     Text format     Abstract available


  9. BLASI A, Calvo A, Prado V, Reverter E, et al
    Coagulation failure in patients with Acute-on-Chronic Liver Failure (ACLF) and decompensated cirrhosis: beyond INR.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30103.
    PubMed     Text format     Abstract available


  10. YAN J, Lei J, Chen L, Deng H, et al
    FAT10 overexpression disturbs WISP1 protein and mRNA expression to promote hepatocellular carcinoma progression.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30105.
    PubMed     Text format     Abstract available


  11. SCHULZE RJ, McNiven MA
    Fasting Inhibits the Recruitment of Kinesin-1 to Lipid Droplets and Stalls Hepatic Triglyceride Secretion.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30104.
    PubMed     Text format    


  12. LIU M, Zhang L, Li H, Hinoue T, et al
    Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor SGI-110 in Hepatocellular Carcinoma.
    Hepatology. 2018 May 18. doi: 10.1002/hep.30091.
    PubMed     Text format     Abstract available


  13. BAJAJ JS, Savidge T, Kassam ZA, Hylemon PB, et al
    Fecal Microbial Transplant for Antibiotic-Associated Disruption in Cirrhosis.
    Hepatology. 2018 May 18. doi: 10.1002/hep.30092.
    PubMed     Text format    


  14. MULLISH BH, McDonald JAK, Thursz MR, Marchesi JR, et al
    Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis is Restored by Fecal Transplant.
    Hepatology. 2018 May 18. doi: 10.1002/hep.30090.
    PubMed     Text format    


  15. WRIGHT TL, Reddy KR
    Thomas D. Boyer, MD: A visionary hepatologist, investigator, mentor and colleague.
    Hepatology. 2018 May 12. doi: 10.1002/hep.30089.
    PubMed     Text format    


  16. SUN P, Lu YX, Cheng D, Zhang K, et al
    Monocyte chemoattractant protein-induced protein 1 targets hypoxia-inducible factor 1alpha to protect against hepatic ischemia/reperfusion injury.
    Hepatology. 2018 May 9. doi: 10.1002/hep.30086.
    PubMed     Text format     Abstract available


  17. WINKLER N, Strubing F, Gross W, Mier W, et al
    Phenomenon of endothelial antibody capture: Principles and potential for locoregional targeting of hepatic tumors.
    Hepatology. 2018 May 7. doi: 10.1002/hep.30072.
    PubMed     Text format     Abstract available


  18. PANG Y, Kartsonaki C, Turnbull I, Guo Y, et al
    Diabetes, plasma glucose and incidence of fatty liver, cirrhosis and liver cancer: A prospective study of 0.5 million people.
    Hepatology. 2018 May 7. doi: 10.1002/hep.30083.
    PubMed     Text format     Abstract available


  19. MANSKE K, Kallin N, Konig V, Schneider A, et al
    Outcome of anti-viral immunity in the liver is shaped by the level of antigen expressed in infected hepatocytes.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30080.
    PubMed     Text format     Abstract available


  20. WANG C, Cheng Y, Zhang X, Li N, et al
    Vacuolar Protein Sorting 33B Is a Tumor Suppressor in Hepatocarcinogenesis.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30077.
    PubMed     Text format     Abstract available


  21. GAO S, Silasi-Mansat R, Behar M, Lupu F, et al
    Excessive plasmin compromises hepatic sinusoidal vascular integrity after acetaminophen overdose.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30070.
    PubMed     Text format     Abstract available


  22. RAEVENS S, Fallon MB
    Potential clinical targets in hepatopulmonary syndrome: lessons from experimental models.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30079.
    PubMed     Text format     Abstract available


  23. SUN P, Zeng Q, Cheng D, Zhang K, et al
    Caspase Recruitment Domain Protein 6 protects against hepatic steatosis and insulin resistance by suppressing Ask1.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30075.
    PubMed     Text format     Abstract available


  24. PROPERZI C, O'Sullivan TA, Sherriff JL, Ching HL, et al
    Ad libitum Mediterranean and Low Fat Diets both Significantly Reduce Hepatic Steatosis: a Randomized Controlled Trial.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30076.
    PubMed     Text format     Abstract available


  25. COHEN-MEKELBURG S, Schwartz RE, Rosenblatt R, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2018;67:1647-1650.
    PubMed     Text format    


    April 2018
  26. LIANG Q, Liu Z, Zhu C, Wang B, et al
    Intrahepatic T cell receptor beta immune repertoire is essential for liver regeneration.
    Hepatology. 2018 Apr 27. doi: 10.1002/hep.30067.
    PubMed     Text format     Abstract available


  27. ALAO H, Cam M, Keembiyehetty C, Zhang F, et al
    Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During DAA Therapy.
    Hepatology. 2018 Apr 27. doi: 10.1002/hep.29921.
    PubMed     Text format     Abstract available


  28. YIN Y, Xu X, Tang J, Zhang W, et al
    CD97 Promotes Tumor Aggressiveness through the Traditional G Protein-Coupled Receptor-mediated signaling in Hepatocellular Carcinoma.
    Hepatology. 2018 Apr 27. doi: 10.1002/hep.30068.
    PubMed     Text format     Abstract available


  29. CULLARO G, Park M, Lai JC
    "Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients with Cirrhosis.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30058.
    PubMed     Text format     Abstract available


  30. TAYLOR AE, Carey AN, Kudira R, Lages CS, et al
    Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30061.
    PubMed     Text format     Abstract available


  31. LUO P, Qin C, Zhu L, Fang C, et al
    Ubiquitin-specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance and Inflammation via Sirt6.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30062.
    PubMed     Text format     Abstract available


  32. YANG JD, Gores GJ
    Does Cirrhosis Associated with Well Controlled Viral Hepatitis Confer a Risk for Extrahepatic Cancer?
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30063.
    PubMed     Text format    


  33. VERRIER ER, Yim SA, Heydmann L, El Saghire H, et al
    Hepatitis B virus evasion from cGAS sensing in human hepatocytes.
    Hepatology. 2018 Apr 20. doi: 10.1002/hep.30054.
    PubMed     Text format     Abstract available


  34. IZZY M, Oh J, Watt KD
    Cirrhotic cardiomyopathy after transplantation: Neither the transient nor innocent bystander.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30040.
    PubMed     Text format     Abstract available


  35. KWONG AJ, Kim WR, Flemming JA
    De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30045.
    PubMed     Text format     Abstract available


  36. KO E, Kim JS, Ju S, Seo HW, et al
    Oxidatively modified PDIA3 promotes DKC1-mediated malignancy and survival of hepatocellular carcinoma cells.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30039.
    PubMed     Text format     Abstract available


  37. LEMMER A, Van-Wagner LB, Ganger D
    Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients with Congestive Hepatopathy.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30048.
    PubMed     Text format     Abstract available


  38. PONZIANI FR, Bhoori S, Castelli C, Putignani L, et al
    Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease.
    Hepatology. 2018 Apr 17. doi: 10.1002/hep.30036.
    PubMed     Text format     Abstract available


  39. BAJAJ JS, Kakiyama G, Savidge T, Takei H, et al
    Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis is Restored by Fecal Transplant.
    Hepatology. 2018 Apr 17. doi: 10.1002/hep.30037.
    PubMed     Text format     Abstract available


  40. MARRONE G, De Chiara F, Bottcher K, Levi A, et al
    The AMPK-v-ATPase-pH axis: A key regulator of the pro-fibrogenic phenotype of human hepatic stellate cells.
    Hepatology. 2018 Apr 17. doi: 10.1002/hep.30029.
    PubMed     Text format     Abstract available


  41. ALLAIRE M, Nahon P, Layese R, Bourcier V, et al
    Extra hepatic cancers are the leading cause of death in cirrhotic patients achieving HBV control or HCV eradication.
    Hepatology. 2018 Apr 16. doi: 10.1002/hep.30034.
    PubMed     Text format     Abstract available


  42. WANG C, Tong Y, Wen Y, Cai J, et al
    Hepatocellular Carcinoma-associated Protein TD26 Interacts and Enhances SREBP1 Activity to Promote Tumor Cell Proliferation and Growth.
    Hepatology. 2018 Apr 16. doi: 10.1002/hep.30030.
    PubMed     Text format     Abstract available


  43. VAN GOLEN RF, Reiniers MJ, van Gorp J, Tushuizen ME, et al
    Utilizing mechanistic biomarkers in treating paracetamol hepatotoxicity.
    Hepatology. 2018 Apr 16. doi: 10.1002/hep.30028.
    PubMed     Text format    


  44. WOO HG, Kim YJ
    Multi-platform genomic roadmap of hepatocellular carcinoma: A matter of molecular heterogeneity.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29925.
    PubMed     Text format    


  45. WENDUM D, Layese R, Ganne-Carrie N, Bourcier V, et al
    Influence of progenitor-derived regeneration markers on HCV-related cirrhosis outcome (ANRS CO12 CirVir cohort).
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29927.
    PubMed     Text format     Abstract available


  46. ZHANG F, Hu Z, Li G, Huo S, et al
    Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29926.
    PubMed     Text format     Abstract available


  47. FANG JH, Zhang ZJ, Shang LR, Luo YW, et al
    Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29920.
    PubMed     Text format     Abstract available


  48. LI H, Feng D, Cai Y, Liu Y, et al
    Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and NETs.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29919.
    PubMed     Text format     Abstract available


  49. XIE L, Yin J, Xia R, Zhuang G, et al
    Cost-effectiveness of antiviral treatment after resection in HBV-related hepatocellular carcinoma patients with compensated cirrhosis.
    Hepatology. 2018 Apr 7. doi: 10.1002/hep.29922.
    PubMed     Text format     Abstract available


  50. CLOYD JM, Pawlik TM
    Diagnostic and Therapeutic Implications of Novel Peptides in Hepatocellular Carcinoma.
    Hepatology. 2018 Apr 7. doi: 10.1002/hep.29923.
    PubMed     Text format    


  51. MARRERO JA, Kulik LM, Sirlin C, Zhu AX, et al
    Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2018 Apr 6. doi: 10.1002/hep.29913.
    PubMed     Text format    


  52. VARGA ZV, Erdelyi K, Paloczi J, Cinar R, et al
    Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome.
    Hepatology. 2018 Apr 6. doi: 10.1002/hep.29915.
    PubMed     Text format     Abstract available


  53. VAN DER WINDT DJ, Sud V, Zhang H, Varley PR, et al
    Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in non-alcoholic steatohepatitis.
    Hepatology. 2018 Apr 6. doi: 10.1002/hep.29914.
    PubMed     Text format     Abstract available


  54. NIEC R, Schwartz RE, Rosenblatt R, Gupta V, et al
    Hepatology Highlights.
    Hepatology. 2018;67:1195-1197.
    PubMed     Text format    


    March 2018
  55. FIRL DJ, Kimura S, McVey J, Hashimoto K, et al
    Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with HALTHCC improves ablate and wait strategy.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29907.
    PubMed     Text format     Abstract available


  56. BHANJI RA, Watt KD
    Reply to letter to the editor: "Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis".
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29908.
    PubMed     Text format    


  57. FAILLACI F, Marzi L, Critelli R, Milosa F, et al
    Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29911.
    PubMed     Text format     Abstract available


  58. KUREBAYASHI Y, Ojima H, Tsujikawa H, Kubota N, et al
    Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification.
    Hepatology. 2018 Mar 30. doi: 10.1002/hep.29904.
    PubMed     Text format     Abstract available


  59. PAYANCE A, Silva-Junior G, Bissonnette J, Tanguy M, et al
    Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis.
    Hepatology. 2018 Mar 30. doi: 10.1002/hep.29903.
    PubMed     Text format     Abstract available


  60. WU J, Zhao Y, Park YK, Lee JY, et al
    Loss of PDK4 switches the hepatic NF-kappaB/TNF pathway from pro-survival to pro-apoptosis.
    Hepatology. 2018 Mar 30. doi: 10.1002/hep.29902.
    PubMed     Text format     Abstract available


  61. YOUNOSSI ZM
    Reply letter to the editor: Combination Therapy for Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2018 Mar 30. doi: 10.1002/hep.29896.
    PubMed     Text format    


  62. MELLINGER JL, Shedden K, Winder GS, Tapper E, et al
    The High Burden of Alcoholic Cirrhosis in Privately Insured Persons in the United States.
    Hepatology. 2018 Mar 26. doi: 10.1002/hep.29887.
    PubMed     Text format     Abstract available


  63. SLIJEPCEVIC D, Roscam Abbing RLP, Fuchs CD, Haazen LCM, et al
    NTCP inhibition has hepatoprotective effects in cholestasis in mice.
    Hepatology. 2018 Mar 24. doi: 10.1002/hep.29888.
    PubMed     Text format     Abstract available


  64. NAULT JC, Couchy G, Caruso S, Meunier L, et al
    ASS1 and peri-portal gene expression in sonic hedgehog hepatocellular adenomas.
    Hepatology. 2018 Mar 24. doi: 10.1002/hep.29884.
    PubMed     Text format     Abstract available


  65. CAUSSY C, Hsu C, Lo MT, Liu A, et al
    Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD.
    Hepatology. 2018 Mar 23. doi: 10.1002/hep.29892.
    PubMed     Text format     Abstract available


  66. CHEN Z, Gao W, Pu L, Zhang L, et al
    PRDM8 Exhibits Anti-Tumor Activities Toward Hepatocellular Carcinoma by Targeting NAP1L1.
    Hepatology. 2018 Mar 23. doi: 10.1002/hep.29890.
    PubMed     Text format     Abstract available


  67. HYUN MH, Lee YS, Kim JH, Lee CU, et al
    Hepatic Resection Compared to Chemoembolization in Intermediate to Advanced Stage Hepatocellular Carcinoma: A Meta-analysis of High-Quality Studies.
    Hepatology. 2018 Mar 15. doi: 10.1002/hep.29883.
    PubMed     Text format     Abstract available


  68. VANWAGNER LB, Kanwal F
    Hepatology in a Changing Health Care Landscape: A Call for Health Services Research.
    Hepatology. 2018 Mar 14. doi: 10.1002/hep.29880.
    PubMed     Text format     Abstract available


  69. FUNG J, Cheung KS, Wong DK, Mak LY, et al
    Long Term Outcomes and Predictive Scores for Hepatocellular Carcinoma and HBsAg Seroclearance after HBeAg Seroclearance.
    Hepatology. 2018 Mar 13. doi: 10.1002/hep.29874.
    PubMed     Text format     Abstract available


  70. ZHANG D, Tong X, Nelson BB, Jin E, et al
    The hepatic BMAL1/AKT/Lipogenesis axis protects against alcoholic liver disease via promoting PPARalpha pathway.
    Hepatology. 2018 Mar 13. doi: 10.1002/hep.29878.
    PubMed     Text format     Abstract available


  71. MOYLAN CA, Abdelmalek MF
    Nonalcoholic Fatty Liver Disease with Cirrhosis Increases Familial Risk for Advanced Fibrosis.
    Hepatology. 2018 Mar 13. doi: 10.1002/hep.29879.
    PubMed     Text format    


  72. WU Y, Shan B, Dai J, Xia Z, et al
    Dual Role for Inositol-requiring Enzyme 1alpha in Promoting the Development of Hepatocellular Carcinoma during Diet-induced Obesity.
    Hepatology. 2018 Mar 5. doi: 10.1002/hep.29871.
    PubMed     Text format     Abstract available


  73. PHILIPS CA, Augustine P, Mathew S, Valiathan GC, et al
    Letter to the editor: Growth factor therapy for decompensated cirrhosis - Much ado about nothing?
    Hepatology. 2018 Mar 3. doi: 10.1002/hep.29866.
    PubMed     Text format    


  74. ZHANG XP, Wang K, Guo WX, Chen ZH, et al
    Is sorafenib an optimal treatment for hepatocellular carcinoma with macrovascular invasion or metastatic disease?
    Hepatology. 2018 Mar 3. doi: 10.1002/hep.29862.
    PubMed     Text format    


  75. ROSENBLATT R, Brown RS Jr., Mukewar S, Schneider Y, et al
    Hepatology Highlights.
    Hepatology. 2018;67:817-819.
    PubMed     Text format    


    February 2018
  76. HENEGHAN MA, Cannon MD
    Hepatic diagnostics in pregnancy: Biopsy, biomarkers and beyond.
    Hepatology. 2018 Feb 27. doi: 10.1002/hep.29859.
    PubMed     Text format    


  77. WU JF, Lee CS, Lin WH, Jeng YM, et al
    Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy.
    Hepatology. 2018 Feb 27. doi: 10.1002/hep.29856.
    PubMed     Text format     Abstract available


  78. HUANG AC, Mehta N, Dodge JL, Yao FY, et al
    Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
    Hepatology. 2018 Feb 24. doi: 10.1002/hep.29855.
    PubMed     Text format     Abstract available


  79. FOSTER GR, Agarwal K, Cramp ME, Moreea S, et al
    Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial.
    Hepatology. 2018 Feb 23. doi: 10.1002/hep.29852.
    PubMed     Text format     Abstract available


  80. LEBEAUPIN C, Vallee D, Rousseau D, Patouraux S, et al
    Bax Inhibitor-1 protects from Non-Alcoholic Steatohepatitis by limiting IRE1alpha signaling.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29847.
    PubMed     Text format     Abstract available


  81. CHEN H, Shen F, Sherban A, Nocon A, et al
    DEPTOR Suppresses Lipogenesis and Ameliorates Hepatic Steatosis and Acute-on-Chronic Liver Injury in Alcoholic Liver Disease.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29849.
    PubMed     Text format     Abstract available


  82. CAREY W
    Statin Use In Cirrhosis from Fatty Liver Disease.
    Hepatology. 2018 Feb 14. doi: 10.1002/hep.29842.
    PubMed     Text format    


  83. ZHU W, Peng Y, Wang L, Hong Y, et al
    Identification of alpha-fetoprotein-specific T cell receptors for hepatocellular carcinoma immunotherapy.
    Hepatology. 2018 Feb 14. doi: 10.1002/hep.29844.
    PubMed     Text format     Abstract available


  84. KLEINER DE
    Hepatocellular Carcinoma: Liver Biopsy in the Balance.
    Hepatology. 2018 Feb 5. doi: 10.1002/hep.29831.
    PubMed     Text format     Abstract available


  85. JING R, Zhou X, Zhao J, Wei Y, et al
    Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and human in vitro.
    Hepatology. 2018 Feb 5. doi: 10.1002/hep.29829.
    PubMed     Text format     Abstract available


  86. WANG M, Ju C
    Orchestrating liver repair - a newly discovered function of hepatic iNKT cells.
    Hepatology. 2018 Feb 5. doi: 10.1002/hep.29828.
    PubMed     Text format    


  87. OLAIZOLA P, Perugorria MJ, Banales JM
    Towards Personalized Medicine for Intrahepatic Cholangiocarcinoma: Pharmacogenomic Stratification of Patients.
    Hepatology. 2018 Feb 2. doi: 10.1002/hep.29830.
    PubMed     Text format    


    January 2018
  88. JUN G, Fang C, Zhang P, Wang PX, et al
    Tumor progression locus 2 in hepatocytes potentiates both liver and systemic metabolic disorders.
    Hepatology. 2018 Jan 30. doi: 10.1002/hep.29820.
    PubMed     Text format     Abstract available


  89. PU W, Li J, Zheng Y, Shen X, et al
    Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.
    Hepatology. 2018 Jan 30. doi: 10.1002/hep.29819.
    PubMed     Text format     Abstract available


  90. RIDOLA L, Riggio O
    Prediction of Hepatic Encephalopathy: Why disregard well known risk factors?
    Hepatology. 2018 Jan 29. doi: 10.1002/hep.29808.
    PubMed     Text format    


  91. LIU X, Guo GL, Kong B, Hilburn DB, et al
    Farnesoid X Receptor Signaling Activates the Hepatic X-box Binding Protein 1 Pathway in vitro and in Mice.
    Hepatology. 2018 Jan 29. doi: 10.1002/hep.29815.
    PubMed     Text format     Abstract available


  92. TAPPER EB, Ratz D, Lok AS, Su GL, et al
    Re: Prediction of Hepatic Encephalopathy: why disregard well known risk factors?
    Hepatology. 2018 Jan 24. doi: 10.1002/hep.29806.
    PubMed     Text format    


  93. KOSTALLARI E, Hirsova P, Prasnicka A, Verma VK, et al
    Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.
    Hepatology. 2018 Jan 23. doi: 10.1002/hep.29803.
    PubMed     Text format     Abstract available


  94. BRUNT E, Aishima S, Clavien PA, Fowler K, et al
    cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.
    Hepatology. 2018 Jan 23. doi: 10.1002/hep.29789.
    PubMed     Text format     Abstract available


  95. BERZIGOTTI A, Bosch J
    Reply to "Balancing exercise-induced weight loss with protein caloric requirement remains a challenge in overweight patients with cirrhosis".
    Hepatology. 2018 Jan 22. doi: 10.1002/hep.29799.
    PubMed     Text format    


  96. DHALIWAL A, Towey J, Haydon G, Elsharkawy AM, et al
    Balancing exercise-induced weight loss with protein caloric requirement remains a challenge in overweight patients with cirrhosis.
    Hepatology. 2018 Jan 22. doi: 10.1002/hep.29801.
    PubMed     Text format    


  97. WANG X, Du H, Shao S, Bo T, et al
    Cyclophilin D Deficiency Attenuates Mitochondrial Perturbation and Ameliorates Hepatic Steatosis.
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29788.
    PubMed     Text format     Abstract available


  98. LO GH
    Does antiplatelet therapy really reduce the risk of hepatocellular carcinoma in hepatitis B patients with antiviral drug?
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29794.
    PubMed     Text format    


  99. LU M, Wu J, Hao ZW, Shang YK, et al
    Basolateral CD147 Induces Hepatocyte Polarity Loss by E-cadherin Ubiquitination and Degradation in Hepatocellular Carcinoma Progress.
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29798.
    PubMed     Text format     Abstract available


  100. FERNANDEZ M
    Placental Growth Factor: New Treatment Target Bringing Hope in Hepatopulmonary Syndrome.
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29795.
    PubMed     Text format    


  101. WANG X, Zhang M, Ping F, Liu H, et al
    Identification and Therapeutic Intervention of Co-activated ALK, FGFR2 and EphA5 Kinases in Hepatocellular Carcinoma.
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29792.
    PubMed     Text format     Abstract available


  102. YEN CJ, Ai YL, Tsai HW, Chan SH, et al
    Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29790.
    PubMed     Text format     Abstract available


  103. KAGEYAMA S, Nakamura K, Fujii T, Ke B, et al
    Recombinant Relaxin Protects Liver Transplants from Ischemia Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29787.
    PubMed     Text format     Abstract available


  104. BAJAJ JS, Idilman R, Mabudian L, Hood M, et al
    Diet Affects Gut Microbiota and Modulates Hospitalization Risk Differentially In an International Cirrhosis Cohort.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29791.
    PubMed     Text format     Abstract available


  105. ZHAO Z, Xu D, Wang Z, Wang L, et al
    Hepatic PPARalpha function is controlled by polyubiquitination and proteasome-mediated degradation via the coordinated actions of PAQR3 and HUWE1.
    Hepatology. 2018 Jan 13. doi: 10.1002/hep.29786.
    PubMed     Text format     Abstract available


  106. WU SY, Lan SH, Wu SR, Chiu YC, et al
    Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system.
    Hepatology. 2018 Jan 12. doi: 10.1002/hep.29781.
    PubMed     Text format     Abstract available


  107. BOTTCHER K, Rombouts K, Saffioti F, Roccarina D, et al
    MAIT cells are chronically activated in patients with autoimmune liver disease and promote pro-fibrogenic hepatic stellate cell activation.
    Hepatology. 2018 Jan 12. doi: 10.1002/hep.29782.
    PubMed     Text format     Abstract available


  108. ZHENG H, Pomyen Y, Hernandez MO, Li C, et al
    Single cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma.
    Hepatology. 2018 Jan 9. doi: 10.1002/hep.29778.
    PubMed     Text format     Abstract available


  109. PATIDAR KR, Kang L, Bajaj JS, Carl D, et al
    Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis.
    Hepatology. 2018 Jan 8. doi: 10.1002/hep.29772.
    PubMed     Text format     Abstract available


  110. O'LEARY JG, Reddy KR, Garcia-Tsao G, Biggins SW, et al
    NACSELD Acute-on-Chronic Liver Failure (NACSELD-ACLF) Score Predicts 30-Day Survival in Hospitalized Patients with Cirrhosis.
    Hepatology. 2018 Jan 8. doi: 10.1002/hep.29773.
    PubMed     Text format     Abstract available


  111. PALARIA A, Angelo JR, Guertin T, Mager J, et al
    Patterning of the hepato-pancreatobiliary boundary by BMP reveals heterogeneity within the murine liver bud.
    Hepatology. 2018 Jan 5. doi: 10.1002/hep.29769.
    PubMed     Text format     Abstract available


  112. NOVIKOV A, Schwartz RE, Mukewar S, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2018;67:1-3.
    PubMed     Text format    


  113. VUPPALANCHI R, Siddiqui MS, Van Natta ML, Hallinan E, et al
    Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease.
    Hepatology. 2018;67:134-144.
    PubMed     Text format     Abstract available


  114. GAGGINI M, Carli F, Rosso C, Buzzigoli E, et al
    Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.
    Hepatology. 2018;67:145-158.
    PubMed     Text format     Abstract available


  115. ESTES C, Razavi H, Loomba R, Younossi Z, et al
    Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
    Hepatology. 2018;67:123-133.
    PubMed     Text format     Abstract available


  116. ZHANG J, Li Z, Liu L, Wang Q, et al
    Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway.
    Hepatology. 2018;67:171-187.
    PubMed     Text format     Abstract available


  117. AYONRINDE OT, Adams LA, Mori TA, Beilin LJ, et al
    Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents.
    Hepatology. 2018;67:108-122.
    PubMed     Text format     Abstract available


  118. WREE A, Inzaugarat ME, Feldstein AE
    Transmembrane BAX Inhibitor motif-containing 1, a novel anti-inflammatory approach for nonalcoholic steatohepatitis treatment.
    Hepatology. 2018;67:438-441.
    PubMed     Text format    


  119. SINGH S, Loomba R
    Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases.
    Hepatology. 2018;67:13-15.
    PubMed     Text format    


  120. SARKAR M, Baffy G
    Perinatal programming of adolescent nonalcoholic fatty liver disease: A case for gender inequality?
    Hepatology. 2018;67:7-9.
    PubMed     Text format    


  121. CHALASANI N, Younossi Z, Lavine JE, Charlton M, et al
    The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Hepatology. 2018;67:328-357.
    PubMed     Text format    


    December 2017
  122. ZIOL M, Pote N, Amaddeo G, Laurent A, et al
    Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.
    Hepatology. 2017 Dec 27. doi: 10.1002/hep.29762.
    PubMed     Text format     Abstract available


  123. VERMA N, Kaur A, Sharma R, Bhalla A, et al
    Outcomes after Multiple courses of Granulocyte-Colony Stimulating Factor and Growth Hormone in Decompensated Cirrhosis: Randomized Trial.
    Hepatology. 2017 Dec 26. doi: 10.1002/hep.29763.
    PubMed     Text format     Abstract available


  124. NEPAL C, O'Rourke CJ, Oliveira DV, Taranta A, et al
    Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma.
    Hepatology. 2017 Dec 26. doi: 10.1002/hep.29764.
    PubMed     Text format     Abstract available


  125. TAPPER EB, Kanwal F, Asrani SK, Ho C, et al
    Patient Reported Outcomes in Cirrhosis: A Scoping Review of the Literature.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29756.
    PubMed     Text format     Abstract available


  126. YOSHIHARA T, Sakamori R, Furuta K, Shigekawa M, et al
    Hepatocellular Carcinoma Due to a Baffle Obstruction After the Mustard Operation: A Case Report.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29758.
    PubMed     Text format     Abstract available


  127. MORELLO E, Sutti S, Foglia B, Novo E, et al
    Hypoxia-inducible factor 2alpha drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29754.
    PubMed     Text format     Abstract available


  128. KIM DY, Han KH
    Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update?
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29748.
    PubMed     Text format    


  129. SO J, Khaliq M, Evason K, Ninov N, et al
    Wnt/beta-catenin signaling controls intrahepatic biliary network formation in zebrafish by regulating Notch activity.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29752.
    PubMed     Text format     Abstract available


  130. TAPPER EB, Lok AS, Su GL
    Re: Risk stratification of suffering hepatic encephalopathy in liver cirrhosis patients: novel strategy with novel concerns.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29746.
    PubMed     Text format    


  131. ZHENG B, Zhu YJ, Jeong S, Wang HY, et al
    Risk stratification ofhepatic encephalopathy in liver cirrhosis patients: Novel strategy with novel concerns.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29747.
    PubMed     Text format    


  132. CHO CS, Park HW, Ho A, Semple IA, et al
    Lipotoxicity induces hepatic protein inclusions through TBK1-mediated p62/SQSTM1 phosphorylation.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29742.
    PubMed     Text format     Abstract available


  133. ZOU X, Ramachandran P, Kendall TJ, Pellicoro A, et al
    11betaHSD1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29734.
    PubMed     Text format     Abstract available


  134. SHAN Z, Liu X, Chen Y, Wang M, et al
    Chitinase 3-like-1 Promotes Intrahepatic Activation of Coagulation Through Induction of Tissue Factor in Mice.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29733.
    PubMed     Text format     Abstract available


  135. KIM E, Kim D, Lee JS, Yoe J, et al
    Capicua suppresses hepatocellular carcinoma progression by controlling ETV4-MMP1 axis.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29738.
    PubMed     Text format     Abstract available


  136. SU TH, Tseng TC, Kao JH
    HCC risk in patients with HBV-related cirrhosis receiving NA therapy: is HCC prevented or delayed?
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29740.
    PubMed     Text format    


  137. SPELIOTES EK
    Thwart your destiny; effect of NAFLD genes on steatosis, liver injury and cirrhosis varies by body mass index.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29739.
    PubMed     Text format    


  138. BRISEBOIS A, Ismond KP, Carbonneau M, Tandon P, et al
    Advance Care Planning (ACP) for specialists managing cirrhosis: a focus on patient-centered care.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29731.
    PubMed     Text format     Abstract available


  139. ALI AH, Tabibian JH, Naser-Ghodsi N, Lennon RJ, et al
    Surveillance for Hepatobiliary Cancers in Patients with Primary Sclerosing Cholangitis.
    Hepatology. 2017 Dec 15. doi: 10.1002/hep.29730.
    PubMed     Text format     Abstract available


  140. QVARTSKHAVA N DR, Jin CJ Dr, Gorg B Dr, Haussinger D Prof Dr, et al
    Comment on Haakvort et al. 2017, Hepatology 65:281-293.
    Hepatology. 2017 Dec 12. doi: 10.1002/hep.29727.
    PubMed     Text format    


  141. GARCIA-TSAO G
    Regression of HCV cirrhosis: Time will tell.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29720.
    PubMed     Text format    


  142. YOUNOSSI ZM, Loomba R, Anstee QM, Rinella ME, et al
    Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29721.
    PubMed     Text format     Abstract available


  143. TAPPER EB, Loomba R
    NAFLD, Metabolic Syndrome, and the Fight That Will Define Clinical Practice for a Generation of Hepatologists.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29722.
    PubMed     Text format    


  144. YOUNOSSI ZM, Loomba R, Rinella ME, Bugianesi E, et al
    Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29724.
    PubMed     Text format     Abstract available


  145. PINATO DJ
    Breaking Kuhn's paradigm in advanced hepatocellular carcinoma.
    Hepatology. 2017 Dec 8. doi: 10.1002/hep.29714.
    PubMed     Text format    


  146. ZHANG H, Li X, Yang Y, Zhang Y, et al
    Significance and Mechanism of Androgen Receptor (AR) Overexpression and AR-mTOR Crosstalk in Hepatocellular Carcinoma.
    Hepatology. 2017 Dec 8. doi: 10.1002/hep.29715.
    PubMed     Text format     Abstract available


  147. MASYUK TV, Masyuk AI, LaRusso NF
    Polycystic Liver Disease: The interplay of genes causative for hepatic and renal cystogenesis.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29708.
    PubMed     Text format    


  148. VAN DE GRAAF S, Slijepcevic D
    Reply to D Levy - HEPATOLOGY.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29709.
    PubMed     Text format    


  149. LEVY D
    The role of mEH, NTCP and OATP in hepatic sodium-dependent bile acid transport.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29712.
    PubMed     Text format    


  150. KAKABADZE Z, Kakabadze A, Chakhunashvili D, Karalashvili L, et al
    Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29713.
    PubMed     Text format     Abstract available


  151. LI DK, Ren Y, Fierer DS, Rutledge S, et al
    The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study.
    Hepatology. 2017 Dec 2. doi: 10.1002/hep.29707.
    PubMed     Text format     Abstract available



  152. 2017 Hepatology referees (volumes 65 and 66).
    Hepatology. 2017;66:2096-2101.
    PubMed     Text format    


  153. TOW C, Brown RS Jr, Tafesh ZH, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1709-1712.
    PubMed     Text format    


  154. BHANJI RA, Narayanan P, Allen AM, Malhi H, et al
    Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Hepatology. 2017;66:2055-2065.
    PubMed     Text format     Abstract available


  155. PETTA S, Valenti L, Tuttolomondo A, Dongiovanni P, et al
    Interferon lambda 4 rs368234815 TT>deltaG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
    Hepatology. 2017;66:1885-1893.
    PubMed     Text format     Abstract available


  156. HU Y, Shin DJ, Pan H, Lin Z, et al
    YAP suppresses gluconeogenic gene expression through PGC1alpha.
    Hepatology. 2017;66:2029-2041.
    PubMed     Text format     Abstract available


  157. LI XF, Chen C, Xiang DM, Qu L, et al
    Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.
    Hepatology. 2017;66:1934-1951.
    PubMed     Text format     Abstract available


  158. AUGUSTIN S, Pons M, Maurice JB, Bureau C, et al
    Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Hepatology. 2017;66:1980-1988.
    PubMed     Text format     Abstract available


  159. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Lower effectiveness of hepatitis C antiviral treatment in patients with hepatocellular carcinoma: Is active tumor the clue?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29700.
    PubMed     Text format    


  160. JI F, Yeo YH, Wei MT, Wei B, et al
    Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: does direct-acting antiviral regimens matter?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29701.
    PubMed     Text format    


  161. LIU X, Green RM
    Beyond Farnesoid X receptor to target new therapies for NAFLD.
    Hepatology. 2017;66:1724-1726.
    PubMed     Text format    


  162. WANG C, Bernards R
    In vivo veritas: Finding novel genes involved in liver cancer through in vivo genetic screens.
    Hepatology. 2017;66:2078-2080.
    PubMed     Text format    


    November 2017
  163. SINGH AK, Rooge SB, Varshney A, Vasudevan M, et al
    Global micro RNA expression profiling in the liver biopsies of Hepatitis B Virus infected patients suggests specific miRNA signatures for viral persistence and hepatocellular injury.
    Hepatology. 2017 Nov 30. doi: 10.1002/hep.29690.
    PubMed     Text format     Abstract available


  164. CHANG FM, Wang YP, Lu CL
    Reply: Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29686.
    PubMed     Text format    


  165. LIN CY
    Statins and risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: Methodological issues.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29687.
    PubMed     Text format    


  166. LO GH, Reiberger T
    Peptic ulcer bleeding in cirrhotic patients: Is as bad as variceal bleeding?
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29680.
    PubMed     Text format     Abstract available


  167. ZHANG J, Zhang Q, Lou Y, Fu Q, et al
    HIF-1alpha/IL-1beta signaling enhances hepatoma epithelial-mesenchymal transition via macrophages in a hypoxic-inflammatory microenvironment.
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29681.
    PubMed     Text format     Abstract available


  168. PENG JM, Bera R, Chiou CY, Yu MC, et al
    Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis.
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29678.
    PubMed     Text format     Abstract available


  169. BORZIO M, Dionigi E, Rossini A, Marignani M, et al
    External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. (HEP-17-0903).
    Hepatology. 2017 Nov 22. doi: 10.1002/hep.29662.
    PubMed     Text format     Abstract available


  170. GIANNINI EG, Bucci L, Garuti F, Brunacci M, et al
    Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29668.
    PubMed     Text format     Abstract available


  171. CAST A, Valanejad L, Wright M, Nguyen P, et al
    C/EBPalpha-dependent pre-neoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29677.
    PubMed     Text format     Abstract available


  172. ZHANG XP, Wang K, Chen ZH, Cheng SQ, et al
    Hepatocellular carcinoma with hepatic vein invasion should not be considered as a contraindication for liver resection.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29665.
    PubMed     Text format    


  173. HOOKS KB, Audoux J, Fazli H, Lesjean S, et al
    New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29672.
    PubMed     Text format     Abstract available


  174. PEI Y, Chen XP, Zhang W
    Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: more details, more significance.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29666.
    PubMed     Text format    


  175. SIMON TG, King LY, Chong DQ, Nguyen L, et al
    Diabetes, Metabolic Comorbidities and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29660.
    PubMed     Text format     Abstract available


  176. PARK H, O'Brien TR, Rehermann B
    The role of genetics in hepatic fibrosis amongst HCV patients.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29659.
    PubMed     Text format    


  177. LIANG Y, Feng Y, Zong M, Wei X, et al
    beta-Catenin Deficiency in Hepatocytes Aggravates Hepatocarcinogenesis Driven by Oncogenic beta-Catenin and MET.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29661.
    PubMed     Text format     Abstract available


  178. CHAUHAN A, Adams DH
    Exercise alters the hepatic immunophenotype to protect against inflammatory liver disease.
    Hepatology. 2017 Nov 16. doi: 10.1002/hep.29657.
    PubMed     Text format    


  179. KAFFE E, Fiorotto R, Pellegrino F, Mariotti V, et al
    beta-catenin and IL-1beta dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis.
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29652.
    PubMed     Text format     Abstract available


  180. LIU C, Yang Z, Wu J, Zhang L, et al
    lncRNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis.
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29654.
    PubMed     Text format     Abstract available


  181. HERMANN A, Wennmann DO, Gromnitza S, Edeling M, et al
    WWC proteins regulate hepatic cell differentiation and tumorigenesis via the Hippo signaling pathway.
    Hepatology. 2017 Nov 8. doi: 10.1002/hep.29647.
    PubMed     Text format     Abstract available


  182. GARCIA-LEZANA T, Raurell I, Bravo M, Torres-Arauz M, et al
    Restoration of A Healthy Intestinal Microbiota Normalizes Portal Hypertension In A Rat Model of Nonalcoholic Steatohepatitis.
    Hepatology. 2017 Nov 7. doi: 10.1002/hep.29646.
    PubMed     Text format     Abstract available


  183. VARSHNEY A, Panda JJ, Singh AK, Yadav N, et al
    Targeted delivery of miR-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29643.
    PubMed     Text format     Abstract available


  184. CAUSSY C, Alquiraish MH, Nguyen P, Hernandez C, et al
    Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29639.
    PubMed     Text format     Abstract available


  185. FAGGIOLI F, Palagano E, Di Tommaso L, Donadon M, et al
    B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
    Hepatology. 2017 Nov 3. doi: 10.1002/hep.29636.
    PubMed     Text format     Abstract available


  186. GUPTA V, Schwartz RE, Shen N, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1367-1369.
    PubMed     Text format    


  187. XIAO G, Zhu S, Xiao X, Yan L, et al
    Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
    Hepatology. 2017;66:1486-1501.
    PubMed     Text format     Abstract available


  188. AMATHIEU R, Al-Khafaji A, Sileanu FE, Foldes E, et al
    Significance of oliguria in critically ill patients with chronic liver disease.
    Hepatology. 2017;66:1592-1600.
    PubMed     Text format     Abstract available


  189. FAN Y, Arechederra M, Richelme S, Daian F, et al
    A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.
    Hepatology. 2017;66:1644-1661.
    PubMed     Text format     Abstract available


  190. NAM EJ, Hayashida K, Aquino RS, Couchman JR, et al
    Syndecan-1 limits the progression of liver injury and promotes liver repair in acetaminophen-induced liver injury in mice.
    Hepatology. 2017;66:1601-1615.
    PubMed     Text format     Abstract available


  191. SCHWIMMER JB, Behling C, Angeles JE, Paiz M, et al
    Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2017;66:1474-1485.
    PubMed     Text format     Abstract available


  192. LU Y, Jiang Z, Dai H, Miao R, et al
    Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29633.
    PubMed     Text format     Abstract available


  193. RAEMAN R, Anania FA
    Therapy for steatohepatitis: Do macrophages hold the clue?
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29630.
    PubMed     Text format    


  194. CAVIGLIA JM, Yan J, Jang MK, Gwak GY, et al
    MicroRNA-21 and Dicer are Dispensable for Hepatic Stellate Cell Activation and the Development of Liver Fibrosis.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29627.
    PubMed     Text format     Abstract available


  195. TAPPER EB, Parikh N, Sengupta N, Mellinger J, et al
    A Risk Score to Predict the Development of Hepatic Encephalopathy in a Population-Based Cohort of Patients with Cirrhosis.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29628.
    PubMed     Text format     Abstract available


  196. YANG S, Rao J
    Comment on "an endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of Kupffer cell polarization".
    Hepatology. 2017;66:1701-1702.
    PubMed     Text format    


  197. XANTHAKOS SA, Trout AT, Dillman JR
    Magnetic resonance elastography assessment of fibrosis in children with NAFLD: Promising but not perfect.
    Hepatology. 2017;66:1373-1376.
    PubMed     Text format    


  198. SCHWEITZER GG, Klein S
    Exercise and NAFLD: Is it worth the effort?
    Hepatology. 2017;66:1691-1694.
    PubMed     Text format    


  199. DOU C, Zheng X, Liu Q, Tu K, et al
    Is the regulatory effect of PCAF and sirtuin 7 on phosphoglycerate kinase 1 acetylation a universal mechanism underlying hepatocellular carcinoma progression?
    Hepatology. 2017;66:1699-1700.
    PubMed     Text format    


  200. KORF H, van der Merwe S
    Adipose-derived exosomal MicroRNAs orchestrate gene regulation in the liver: Is this the missing link in nonalcoholic fatty liver disease?
    Hepatology. 2017;66:1689-1691.
    PubMed     Text format    


    October 2017
  201. AOKI S, Cobbold M, Zhu AX, Duda DG, et al
    Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage?
    Hepatology. 2017 Oct 27. doi: 10.1002/hep.29617.
    PubMed     Text format    


  202. WANG S, Yan ZZ, Yang X, An S, et al
    Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
    Hepatology. 2017 Oct 27. doi: 10.1002/hep.29616.
    PubMed     Text format     Abstract available


  203. PATEL N, Sheehan-Dare G, Weir J, Verma S, et al
    Cutaneous metastasis as the first presentation of hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29615.
    PubMed     Text format    


  204. SHEN Q, Eun JW, Lee K, Kim HS, et al
    BANF1, PLOD3, SF3B4 as Early-stage Cancer Decision Markers and Drivers of Hepatocellular Carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29606.
    PubMed     Text format     Abstract available


  205. PRAKTIKNJO M, Book M, Luetkens J, Pohlmann A, et al
    Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29602.
    PubMed     Text format     Abstract available


  206. SHEN F, Li Y, Yang Wang, Sozzi V, et al
    Hepatitis B Virus Sensitivity to Interferon-alpha in Hepatocytes is More Associated with Cellular Interferon Response than with Viral Genotype.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29609.
    PubMed     Text format     Abstract available


  207. KO E, Seo HW, Jung G
    Telomere length and ROS levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29604.
    PubMed     Text format     Abstract available


  208. JANSEN C, Moller P, Meyer C, Kolbe CC, et al
    Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29612.
    PubMed     Text format     Abstract available


  209. PHILIPS CA, Kumar L, Augustine P
    Partial Splenic Artery Embolization for Severe Hepatic Myelopathy in Cirrhosis.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29597.
    PubMed     Text format     Abstract available


  210. SHERMAN M
    Regorafenib for treatment of hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29598.
    PubMed     Text format    


  211. MIDDLETON MS, Van Natta ML, Heba ER, Alazraki A, et al
    Diagnostic Accuracy of Magnetic Resonance Imaging Hepatic Proton Density Fat Fraction in Pediatric Nonalcoholic Fatty Liver Disease.
    Hepatology. 2017 Oct 13. doi: 10.1002/hep.29596.
    PubMed     Text format     Abstract available


  212. VON LOEFFELHOLZ C, Birkenfeld AL
    Is mIndy a mediator of energy metabolism reprogramming in hepatocellular carcinoma induced by IL-6/STAT3 signaling?
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29591.
    PubMed     Text format    


  213. LU L, Yue S, Jiang L, Li C, et al
    Myeloid Notch1 Deficiency Activates RhoA/ROCK Pathway and Aggravates Hepatocellular Damage In Mouse Ischemic Livers.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29593.
    PubMed     Text format     Abstract available


  214. TOSKICH B, Patel T
    Radioembolization for hepatocellular carcinoma - the time has come.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29590.
    PubMed     Text format    


  215. CHEN Y, Zeng Z, Lu Y
    Is mIndy a mediator of energy metabolism reprogramming in hepatocellular carcinoma induced by IL-6/STAT3 signaling?
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29592.
    PubMed     Text format    


  216. YANG JD, Mannalithara A, Piscitello AJ, Kisiel JB, et al
    Impact of Surveillance for Hepatocellular Carcinoma on Survival in Patients with Compensated Cirrhosis.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29594.
    PubMed     Text format     Abstract available


  217. EHRLICH L, Glaser SS
    Novel beta-catenin/FXR Interaction Regulates Hepatic Bile Acid Metabolism During Cholestasis.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29584.
    PubMed     Text format    


  218. RAMMOHAN A, Reddy MS, Farouk M, Vargese J, et al
    Pembrolizumab for Metastatic Hepatocellular Carcinoma Following Live Donor Liver Transplantation: The Silver Bullet?
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29575.
    PubMed     Text format     Abstract available


  219. SIDHU SS, Sharma BC, Goyal O, Kishore H, et al
    Reply: Terminating an episode of overt hepatic encephalopathy - L - ornithine L-aspartate may have some role.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29571.
    PubMed     Text format    


  220. WANG F, Hongwei T, Li L, Piontek K, et al
    Exosome - miR-335 as a novel therapeutic strategy in hepatocellular carcinoma.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29586.
    PubMed     Text format     Abstract available


  221. ZHAO J, Adams A, Roberts B, O'Neil M, et al
    PRMT1 and JMJD6 dependent arginine methylation regulate HNF4alpha expression and hepatocyte proliferation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29587.
    PubMed     Text format     Abstract available


  222. RATHI S, Taneja S
    Terminating an episode of overt hepatic encephalopathy- Lornithine L-aspartate may have some role.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29570.
    PubMed     Text format    


  223. MONTANO-LOZA AJ, Mazurak VC, Ebadi M, Meza-Junco J, et al
    Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29578.
    PubMed     Text format     Abstract available


  224. MURPHY AG, Selaru F
    Extracellular vesicles as novel therapeutics in hepatic failure.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29576.
    PubMed     Text format    


  225. MACDONALD S, Andreola F, Bachtiger P, Amoros A, et al
    Cell death markers in cirrhotic patients with acute decompensation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29581.
    PubMed     Text format     Abstract available


  226. MASYUK AI, Masyuk TV, Lorenzo Pisarello MJ, Ding JF, et al
    Cholangiocyte Autophagy Contributes to Hepatic Cystogenesis in Polycystic Liver Disease and Represents a Potential Therapeutic Target.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29577.
    PubMed     Text format     Abstract available


  227. PRADHAN-SUNDD T, Zhou L, Vats R, Jiang A, et al
    Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29585.
    PubMed     Text format     Abstract available


  228. BARBIER L, Ronot M, Aussilhou B, Cauchy F, et al
    Polycystic liver disease: Hepatic venous outflow obstruction lesions of the non-cystic parenchyma have major consequences.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29582.
    PubMed     Text format     Abstract available


  229. RAEVENS S, Geerts A, Paridaens A, Lefere S, et al
    Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29579.
    PubMed     Text format     Abstract available


  230. RUSSO N, Brown RS Jr, Schwartz RE, Rosenblatt R, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1013-1015.
    PubMed     Text format    


  231. ALBILLOS A, Zamora J, Martinez J, Arroyo D, et al
    Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.
    Hepatology. 2017;66:1219-1231.
    PubMed     Text format     Abstract available


  232. SO-ARMAH KA, Lim JK, Lo Re V, Tate JP, et al
    FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.
    Hepatology. 2017;66:1286-1295.
    PubMed     Text format     Abstract available


  233. KOLACHALA VL, Palle S, Shen M, Feng A, et al
    Loss of L-selectin-guided CD8+ , but not CD4+ , cells protects against ischemia reperfusion injury in a steatotic liver.
    Hepatology. 2017;66:1258-1274.
    PubMed     Text format     Abstract available


  234. BASURAY S, Smagris E, Cohen JC, Hobbs HH, et al
    The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation.
    Hepatology. 2017;66:1111-1124.
    PubMed     Text format     Abstract available


  235. BANGEN JM, Hammerich L, Sonntag R, Baues M, et al
    Targeting CCl4 -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice.
    Hepatology. 2017;66:1242-1257.
    PubMed     Text format     Abstract available


  236. LIU Z, Que S, Mardinoglu A
    Rediscussion on linearity between fibrosis stages and mortality risk in nonalcoholic fatty liver disease patients.
    Hepatology. 2017;66:1357-1358.
    PubMed     Text format    


  237. SAFIRI S, Khazaei S, Mansori K, Ayubi E, et al
    Comments on "Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis".
    Hepatology. 2017;66:1358-1359.
    PubMed     Text format    


  238. VALENTI L, Dongiovanni P
    Mutant PNPLA3 I148M protein as pharmacological target for liver disease.
    Hepatology. 2017;66:1026-1028.
    PubMed     Text format    


    September 2017
  239. KAKAR S, Ferrell LD
    Glutamine synthetase staining and CTTNB1 mutation in hepatocellular adenomas.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29567.
    PubMed     Text format    


  240. RIORDAN JD, Feddersen CR, Tschida BR, Jackson P, et al
    Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29565.
    PubMed     Text format     Abstract available


  241. REBOUISSOU S, Bioulac-Sage P, Nault JC, Calderaro J, et al
    Reply to << Glutamine synthetase staining and CTNNB1 mutation in hepatocellular adenomas >>.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29563.
    PubMed     Text format    


  242. OU-YANG Q, Lin XM, Zhu YJ, Zheng B, et al
    Distinct Role of Nuclear Receptor Corepressor 1 Regulated de novo Fatty Acids Synthesis in Liver Regeneration and Hepatocarcinogenesis.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29562.
    PubMed     Text format     Abstract available


  243. TIMCHENKO NA
    Mitochondrial and anabolic pathways in hepatocellular carcinoma.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29559.
    PubMed     Text format    


  244. LUO P, Yin P, Hua R, Tan Y, et al
    A large-scale, multi-center serum metabolite biomarkers identification study for the early detection of hepatocellular carcinoma.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29561.
    PubMed     Text format     Abstract available


  245. CHTIOUI H
    OATP1B1 and DAA treatment for hepatitis C in patients with hepatocellular carcinoma.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29556.
    PubMed     Text format    


  246. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Treatment failure with DAA in hepatocellular carcinoma: More than one explanation?
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29553.
    PubMed     Text format    


  247. KRENKEL O, Puengel T, Govaere O, Abdallah AT, et al
    Therapeutic Inhibition of Inflammatory Monocyte Recruitment Reduces Steatohepatitis and Liver Fibrosis.
    Hepatology. 2017 Sep 21. doi: 10.1002/hep.29544.
    PubMed     Text format     Abstract available


  248. WYLES D, Poordad F, Wang S, Alric L, et al
    Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial.
    Hepatology. 2017 Sep 19. doi: 10.1002/hep.29541.
    PubMed     Text format     Abstract available


  249. LEE MH, Huang YH, Chen HY, Khor CS, et al
    Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29531.
    PubMed     Text format     Abstract available


  250. LO RE O, Fusilli C, Rappa F, Van Haele M, et al
    Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma.
    Hepatology. 2017 Sep 15. doi: 10.1002/hep.29519.
    PubMed     Text format     Abstract available


  251. CESARI M, Frigo AC, Tonon M, Angeli P, et al
    Cardiovascular predictors of death in patients with cirrhosis.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29520.
    PubMed     Text format     Abstract available


  252. WINTERS AC, Tremblay D, Arinsburg S, Mascarenhas J, et al
    Reassessing the Safety Concerns of Utilizing Blood Donations from Patients with Hemochromatosis.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29521.
    PubMed     Text format     Abstract available


  253. PISCAGLIA F, Tovoli F, Pini P, Salvatore V, et al
    A new horizon in the prevention of the postembolization syndrome after Transcatheter Arterial Chemioembolization for hepatocellular carcinoma.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29517.
    PubMed     Text format    


  254. RIMOLA J, Diaz-Gonzalez A, Darnell A, Varela M, et al
    Complete response under sorafenib in patients with hepatocellular carcinoma. Relationship with dermatologic adverse events.
    Hepatology. 2017 Sep 12. doi: 10.1002/hep.29515.
    PubMed     Text format     Abstract available


  255. WANG B, Fu J, Yu T, Xu A, et al
    Contradictory Effects of Mitochondria- and Non-mitochondria-targeted Antioxidants on Hepatocarcinogenesis by Altering DNA Repair.
    Hepatology. 2017 Sep 12. doi: 10.1002/hep.29518.
    PubMed     Text format     Abstract available


  256. LOOMBA R, Lawitz E, Mantry PS, Jayakumar S, et al
    The ASK1 Inhibitor Selonsertib in Patients with Nonalcoholic Steatohepatitis: A Randomized, Phase 2 Trial.
    Hepatology. 2017 Sep 11. doi: 10.1002/hep.29514.
    PubMed     Text format     Abstract available


  257. LIU CH, Chern GG, Hsu FF, Huang KW, et al
    A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia.
    Hepatology. 2017 Sep 8. doi: 10.1002/hep.29513.
    PubMed     Text format     Abstract available


  258. FINN RS, Zhu AX, Wigdan F, Almasri J, et al
    Therapies for Advanced Stage Hepatocellular Carcinoma with Macrovascular invasion or Metastatic Disease: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29486.
    PubMed     Text format     Abstract available


  259. MARSHALL K, Jin J, Atkinson C, Alawieh A, et al
    Natural IgM initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29512.
    PubMed     Text format     Abstract available


  260. BORENTAIN P, Colson P, Bolon E, Gauchez P, et al
    Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis.
    Hepatology. 2017 Sep 5. doi: 10.1002/hep.29508.
    PubMed     Text format    



  261. ERRATUM for Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?
    Hepatology. 2017 Sep 4. doi: 10.1002/hep.29171.
    PubMed     Text format    


  262. SCHWARTZ RE, Batisti J, Brown RS Jr, Tafesh Z, et al
    Hepatology Highlights.
    Hepatology. 2017;66:683-685.
    PubMed     Text format    


  263. BOUATTOUR M, Raymond E, Qin S, Cheng AL, et al
    Recent Developments of c-Met as a Therapeutic Target in Hepatocellular Carcinoma.
    Hepatology. 2017 Sep 1. doi: 10.1002/hep.29496.
    PubMed     Text format     Abstract available


  264. TAKYAR V, Nath A, Beri A, Gharib AM, et al
    How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool.
    Hepatology. 2017;66:825-833.
    PubMed     Text format     Abstract available


  265. KACHAYLO E, Tschuor C, Calo N, Borgeaud N, et al
    PTEN Down-Regulation Promotes beta-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice.
    Hepatology. 2017;66:908-921.
    PubMed     Text format     Abstract available


  266. PEREA L, Coll M, Sanjurjo L, Blaya D, et al
    Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.
    Hepatology. 2017;66:953-968.
    PubMed     Text format     Abstract available


  267. SANGRO B, Martinez-Urbistondo D, Bester L, Bilbao JI, et al
    Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review.
    Hepatology. 2017;66:969-982.
    PubMed     Text format     Abstract available


  268. PANDEY S
    Healthy controls in nonalcoholic fatty liver disease management: A biomedical research perspective.
    Hepatology. 2017;66:1006-1007.
    PubMed     Text format    


  269. LO GH
    Do we need vasoconstrictors up to 5 days after successful hemostasis by ligation of bleeding varices?
    Hepatology. 2017;66:1009.
    PubMed     Text format    


  270. DELLAVANCE A, Ferraz MLG, Cancado ELR, Andrade LEC, et al
    Expansion and intensification of humoral autoimmune response in the transition from preclinical to full-blown primary biliary cholangitis.
    Hepatology. 2017;66:997.
    PubMed     Text format    


    August 2017
  271. ROBERTS LR, Sirlin CB, Zaiem F, Almasri J, et al
    Imaging for the Diagnosis of Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29487.
    PubMed     Text format     Abstract available


  272. KULIK L, Heimbach JK, Zaiem F, Almasri J, et al
    Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29485.
    PubMed     Text format     Abstract available


  273. PICCININ E, Peres C, Bellafante E, Ducheix S, et al
    Hepatic PPARgamma coactivator 1beta drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29484.
    PubMed     Text format     Abstract available


  274. VYAS D, Baptista PM, Brovold M, Moran E, et al
    Self-assembled liver organoids recapitulate hepato-biliary organogenesis in vitro.
    Hepatology. 2017 Aug 23. doi: 10.1002/hep.29483.
    PubMed     Text format     Abstract available


  275. YANG JD, Malhi H
    Green Tea Consumption - A Potential Chemopreventive Measure for Hepatocellular Carcinoma?
    Hepatology. 2017 Aug 21. doi: 10.1002/hep.29481.
    PubMed     Text format    


  276. KABIR TD, Ganda C, Brown RM, Beveridge DJ, et al
    A miR-7/GAS6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
    Hepatology. 2017 Aug 18. doi: 10.1002/hep.29478.
    PubMed     Text format     Abstract available


  277. RIAZ A, Gabr A, Abouchaleh N, Ali R, et al
    Radioembolization for Hepatocellular Carcinoma: Statistical Confirmation of Improved Survival in Responders by Landmark Analyses.
    Hepatology. 2017 Aug 18. doi: 10.1002/hep.29480.
    PubMed     Text format     Abstract available


  278. WARD ES, Ober RJ
    Hepatic function of FcRn revealed: Implications for overcoming drug-mediated hepatotoxicity.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29476.
    PubMed     Text format    


  279. FRIEDMAN SL, Ratziu V, Harrison SA, Abdelmalek MF, et al
    A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29477.
    PubMed     Text format     Abstract available


  280. PARIKH ND, Marrero WJ, Wang J, Steuer J, et al
    Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29473.
    PubMed     Text format     Abstract available


  281. DEMAREZ C, Gerard C, Cordi S, Poncy A, et al
    MiR-337-3p controls hepatobiliary gene expression and transcriptional dynamics during hepatic cell differentiation.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29475.
    PubMed     Text format     Abstract available


  282. DE HAAS RJ, Lim C, Bhangui P, Salloum C, et al
    Curative Salvage Liver Transplantation in Cirrhotic patients with Hepatocellular Carcinoma: An intention-to-treat analysis.
    Hepatology. 2017 Aug 14. doi: 10.1002/hep.29468.
    PubMed     Text format     Abstract available


  283. HALGAND B, Desterke C, Riviere L, Fallot G, et al
    Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29463.
    PubMed     Text format     Abstract available


  284. LIN YH, Wu MH, Huang YH, Yeh CT, et al
    Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29462.
    PubMed     Text format     Abstract available


  285. MATSUDA M, Tsurusaki S, Miyata N, Saijou E, et al
    Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice.
    Hepatology. 2017 Aug 5. doi: 10.1002/hep.29421.
    PubMed     Text format     Abstract available


  286. KRISS M, Burchill M
    HCV and non-hepatic malignancy: Is pre-emptive DAA therapy indicated prior to treatment?
    Hepatology. 2017 Aug 2. doi: 10.1002/hep.29414.
    PubMed     Text format    


  287. SCHNEIDER Y, Brown RS, Saumoy M, Schwartz RE, et al
    Hepatology Highlights - August 2017.
    Hepatology. 2017;66:309-311.
    PubMed     Text format    


  288. STIEDE K, Miao W, Blanchette HS, Beysen C, et al
    Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.
    Hepatology. 2017;66:324-334.
    PubMed     Text format     Abstract available


  289. KOH C, Sakiani S, Surana P, Zhao X, et al
    Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
    Hepatology. 2017;66:591-601.
    PubMed     Text format     Abstract available


  290. LAI JC, Covinsky KE, Dodge JL, Boscardin WJ, et al
    Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Hepatology. 2017;66:564-574.
    PubMed     Text format     Abstract available


  291. LIU S, Sun Y, Jiang M, Li Y, et al
    Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase.
    Hepatology. 2017;66:631-645.
    PubMed     Text format     Abstract available


  292. HUNT CM, Papay JI, Stanulovic V, Regev A, et al
    Drug rechallenge following drug-induced liver injury.
    Hepatology. 2017;66:646-654.
    PubMed     Text format     Abstract available


  293. SAIKIA P, Bellos D, McMullen MR, Pollard KA, et al
    MicroRNA 181b-3p and its target importin alpha5 regulate toll-like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol.
    Hepatology. 2017;66:602-615.
    PubMed     Text format     Abstract available


  294. SANOFF HK, Chang Y, Lund JL, O'Neil BH, et al
    Immortal time bias or sorafenib effect in elderly patients with HCC?
    Hepatology. 2017;66:678-679.
    PubMed     Text format    


  295. PONZETTO A, Perez-Perez GI, Figura N
    Alpha1-antitrypsin deficiency and c-JUN.
    Hepatology. 2017;66:677.
    PubMed     Text format    


  296. HE Y, Gao B
    A small specific-sized hyaluronic acid ameliorates alcoholic liver disease by targeting a small RNA: New hope for therapy?
    Hepatology. 2017;66:321-323.
    PubMed     Text format    


  297. FAN H, Zhu JH
    FABP1 as a novel potential biomarker for predicting mortality in acetaminophen-induced acute liver failure.
    Hepatology. 2017;66:670.
    PubMed     Text format    


  298. GEIER A, Jahn D, Hermanns HM
    Interleukin-6: The dark side of liver regeneration in chronic liver disease.
    Hepatology. 2017;66:667-668.
    PubMed     Text format    


  299. ICHIKAWA S, Motosugi U, Oguri M, Onishi H, et al
    Magnetic resonance elastography for prediction of radiation-induced liver disease after stereotactic body radiation therapy.
    Hepatology. 2017;66:664-665.
    PubMed     Text format    


  300. AZOULAY D, Lahat E, Salloum C, Compagnon P, et al
    Heterotopic liver retransplantation for impossible former graft explantation.
    Hepatology. 2017;66:655-657.
    PubMed     Text format    


    July 2017
  301. GU J, Jeong S, Xia Q
    Intrahepatic cholangiocarcinoma arising from HBV Infection may be a highly selected population for liver transplantation.
    Hepatology. 2017 Jul 31. doi: 10.1002/hep.29413.
    PubMed     Text format    


  302. SIDHU SS, Sharma BC, Goyal O, Kishore H, et al
    L-ornithine L-aspartate in bouts of overt hepatic encephalopathy.
    Hepatology. 2017 Jul 27. doi: 10.1002/hep.29410.
    PubMed     Text format     Abstract available


  303. COBB DA, Golden-Mason L, Rosen HR, Hahn YS, et al
    Hepatocyte-derived exosomes promote T follicular regulatory cell expansion during HCV infection.
    Hepatology. 2017 Jul 27. doi: 10.1002/hep.29409.
    PubMed     Text format     Abstract available


  304. TANDON P, Madsen K, Kao D
    Fecal microbiota transplantation for hepatic encephalopathy - ready for prime time?
    Hepatology. 2017 Jul 22. doi: 10.1002/hep.29396.
    PubMed     Text format    


  305. SAUERBRUCH T
    Continuation of non-selective beta-blockers for patients with liver cirrhosis and hemodynamic non-response?
    Hepatology. 2017 Jul 22. doi: 10.1002/hep.29394.
    PubMed     Text format    


  306. ZHU L, Baker RD, Zhu R, Baker SS, et al
    Sequencing the gut metagenome as a non-invasive diagnosis for advanced nonalcoholic steatohepatitis.
    Hepatology. 2017 Jul 21. doi: 10.1002/hep.29387.
    PubMed     Text format    


  307. LI H, Li X, Liu S, Guo L, et al
    PD-1 Checkpoint Blockade in Combination with an mTOR Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1.
    Hepatology. 2017 Jul 21. doi: 10.1002/hep.29360.
    PubMed     Text format     Abstract available


  308. PEDERSEN JS, Kimer N, Henriksen JH, Bendtsen F, et al
    The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort.
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29386.
    PubMed     Text format    


  309. HIJMANS BS, Boss A, van Dijk TH, Soty M, et al
    Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29389.
    PubMed     Text format     Abstract available


  310. KALAFATELI M, Tsochatzis EA
    Reply to "The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort."
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29391.
    PubMed     Text format    


  311. FU Y, Silverstein S, McCutcheon JN, Dyba M, et al
    An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.
    Hepatology. 2017 Jul 18. doi: 10.1002/hep.29380.
    PubMed     Text format     Abstract available


  312. AN S, Zhao LP, Shen LJ, Wang S, et al
    USP18 protects against hepatic steatosis and insulin resistance via its DUB activity.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29375.
    PubMed     Text format     Abstract available


  313. MULLISH BH, McDonald JAK, Thursz MR, Marchesi JR, et al
    Correspondence: Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29369.
    PubMed     Text format    


  314. ARDEVOL A, Ibanez-Sanz G, Profitos J, Aracil C, et al
    Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29370.
    PubMed     Text format     Abstract available


  315. WU H, Tao J, Li X, Zhang T, et al
    MicroRNA-206 Prevents the Pathogenesis of Hepatocellular Carcinoma Via Modulating Expression of cMet and Cdk6.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29374.
    PubMed     Text format     Abstract available


  316. PURI P, Daita K, Joyce A, Mirshahi F, et al
    The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
    Hepatology. 2017 Jul 11. doi: 10.1002/hep.29359.
    PubMed     Text format     Abstract available


  317. SARWAR A, Zhou L, Novack V, Tapper EB, et al
    Hospital volume and mortality after trans-jugular intrahepatic portosystemic shunt creation in the United States.
    Hepatology. 2017 Jul 6. doi: 10.1002/hep.29354.
    PubMed     Text format     Abstract available


  318. YANG L, Wang WH, Qiu WL, Guo Z, et al
    A single-cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation.
    Hepatology. 2017 Jul 6. doi: 10.1002/hep.29353.
    PubMed     Text format     Abstract available



  319. Hepatology Highlights.
    Hepatology. 2017;66:1-3.
    PubMed     Text format    


  320. CASSANO M, Offner S, Planet E, Piersigilli A, et al
    Polyphenic trait promotes liver cancer in a model of epigenetic instability in mice.
    Hepatology. 2017;66:235-251.
    PubMed     Text format     Abstract available


  321. PICCOLO P, Annunziata P, Soria LR, Attanasio S, et al
    Down-regulation of hepatocyte nuclear factor-4alpha and defective zonation in livers expressing mutant Z alpha1-antitrypsin.
    Hepatology. 2017;66:124-135.
    PubMed     Text format     Abstract available


  322. UNALP-ARIDA A, Ruhl CE
    Liver fibrosis scores predict liver disease mortality in the United States population.
    Hepatology. 2017;66:84-95.
    PubMed     Text format     Abstract available


  323. MUELLER S, Nahon P, Rausch V, Peccerella T, et al
    Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Hepatology. 2017;66:96-107.
    PubMed     Text format     Abstract available


  324. YI S, Sahni N
    Regulome networks and mutational landscape in liver cancer: An informative path to precision medicine.
    Hepatology. 2017;66:280-282.
    PubMed     Text format    


  325. YIP TC, Wong VW
    How to identify patients with advanced liver disease in the community?
    Hepatology. 2017;66:7-9.
    PubMed     Text format    


  326. CARDOSO FS, Pereira R, Alexandrino G, Bagulho L, et al
    Futility of care in patients with acute-on-chronic liver failure.
    Hepatology. 2017;66:292-294.
    PubMed     Text format    


    June 2017
  327. CHENG X, Xia Y, Serti E, Block PD, et al
    Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection.
    Hepatology. 2017 Jun 30. doi: 10.1002/hep.29348.
    PubMed     Text format     Abstract available


  328. LIU J, Hu X, Chen J, Li X, et al
    Pericentral hepatocytes produce IGF-2 to promote liver regeneration during special injuries.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29340.
    PubMed     Text format     Abstract available


  329. LAI Q, Vitale A, Iesari S, Finkenstedt A, et al
    Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29342.
    PubMed     Text format     Abstract available


  330. HENRIET E, Hammoud AA, Dupuy JW, Dartigues B, et al
    Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29336.
    PubMed     Text format     Abstract available


  331. TSAI CL, Liu WL, Hsu FM, Yang PS, et al
    Targeting Histone deacetylase 4/Ubc9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29328.
    PubMed     Text format     Abstract available


  332. LIU Y, Zhang Y, Wang S, Dong QZ, et al
    Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating IL-8 expression.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29337.
    PubMed     Text format     Abstract available


  333. DAWSON PA
    Hepatic bile acid uptake in humans and mice: Multiple pathways and expanding potential role for gut-liver signaling.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29325.
    PubMed     Text format    


  334. ZHANG C, Huang J, An W
    Hepatic stimulator substance resists hepatic ischemia-reperfusion injury by regulating Drp1 translocation and activation.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29326.
    PubMed     Text format     Abstract available


  335. YIP LY, Aw CC, Lee SH, Hong YS, et al
    The Liver-Gut Microbiota Axis Modulates Hepatotoxicity of Tacrine in the Rat.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29327.
    PubMed     Text format     Abstract available


  336. KIM DS, Ryu JW, Son MY, Oh JH, et al
    A Liver-specific Gene Expression Panel Predicts the Differentiation Status of in vitro Hepatocyte Models.
    Hepatology. 2017 Jun 22. doi: 10.1002/hep.29324.
    PubMed     Text format     Abstract available


  337. PAPATHEODORIDIS GV, Idilman R, Dalekos GN, Buti M, et al
    The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.
    Hepatology. 2017 Jun 16. doi: 10.1002/hep.29320.
    PubMed     Text format     Abstract available


  338. CHIDA T, Ito M, Nakashima K, Kanegae Y, et al
    Critical role of CREBH-mediated induction of TGF-beta2 by HCV infection in fibrogenic responses in hepatic stellate cells.
    Hepatology. 2017 Jun 16. doi: 10.1002/hep.29319.
    PubMed     Text format     Abstract available


  339. LEE M, Chung GE, Lee JH, Oh S, et al
    Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.
    Hepatology. 2017 Jun 15. doi: 10.1002/hep.29318.
    PubMed     Text format     Abstract available


  340. GAO Y, Feng J, Yang G, Zhang S, et al
    HBx-elevated MSL2 Modulates HBV cccDNA through Inducing Degradation of APOBEC3B to Enhance Hepatocarcinogenesis.
    Hepatology. 2017 Jun 13. doi: 10.1002/hep.29316.
    PubMed     Text format     Abstract available


  341. TAYLOR EJ, Jones RL, Guthrie JA, Rowe IA, et al
    Modelling the benefits and harms of surveillance for hepatocellular carcinoma: information to support informed choices.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29315.
    PubMed     Text format     Abstract available


  342. JIANG L, Yan Q, Fang S, Liu M, et al
    Calcium binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating ERK signaling pathway.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29312.
    PubMed     Text format     Abstract available


  343. BALWANI M, Wang B, Anderson KE, Bloomer JR, et al
    Acute Hepatic Porphyrias: Recommendations for Evaluation and Long Term Management.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29313.
    PubMed     Text format     Abstract available


  344. ZHENG C, Zeng H, Lin H, Wang J, et al
    Serum microcystins level positively linked with risk of hepatocellular carcinoma: a case-control study in Southwest China.
    Hepatology. 2017 Jun 9. doi: 10.1002/hep.29310.
    PubMed     Text format     Abstract available


  345. NG CKY, Piscuoglio S, Terracciano LM
    Molecular classification of hepatocellular carcinoma: The view from metabolic zonation.
    Hepatology. 2017 Jun 9. doi: 10.1002/hep.29311.
    PubMed     Text format    


  346. AKINROTIMI O, Riessen R, VanDuyne P, Park JE, et al
    Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29305.
    PubMed     Text format     Abstract available


  347. BAJAJ JS, Kassam Z, Fagan A, Gavis EA, et al
    Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29306.
    PubMed     Text format     Abstract available


  348. KWONG AJ, Goel A, Mannalithara A, Kim WR, et al
    Improved Post-Transplant Mortality After Share 35 for Liver Transplantation.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29301.
    PubMed     Text format     Abstract available


  349. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1783-1784.
    PubMed     Text format    


  350. DOYCHEVA I, Watt KD, Alkhouri N
    Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic.
    Hepatology. 2017;65:2100-2109.
    PubMed     Text format     Abstract available


  351. AJMERA VH, Terrault NA, Harrison SA
    Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Hepatology. 2017;65:2090-2099.
    PubMed     Text format     Abstract available


  352. GIANNINI EG, Savarino V
    Noninvasive assessment of varices needing treatment in patients with advanced chronic liver disease: No one should be left behind.
    Hepatology. 2017;65:2131.
    PubMed     Text format    


  353. KARLAS T, Beer S, Babel J, Busse H, et al
    Do we need controlled attenuation parameter adjustment for fibrosis estimation in nonalcoholic fatty liver disease patients?
    Hepatology. 2017;65:2126-2128.
    PubMed     Text format    


  354. GUNDLING F, Tiller M, Schepp W
    Comment on "esophageal balloon tamponade vs. esophageal stent in controlling acute refractory variceal bleeding: A multicenter RCT".
    Hepatology. 2017;65:2120-2121.
    PubMed     Text format    


  355. ARIAS IM
    Coming of age and building of bridges ... reflections on the past, present, and, hesitatingly, future.
    Hepatology. 2017;65:1785-1788.
    PubMed     Text format    


    May 2017
  356. MARKWARDT D, Holdt L, Steib C, Benesic A, et al
    Plasma Cystatin C is a predictor of renal dysfunction, ACLF and mortality in patients with acutely decompensated liver cirrhosis.
    Hepatology. 2017 May 25. doi: 10.1002/hep.29290.
    PubMed     Text format     Abstract available


  357. WANG Z, Han J, Zhang H, Wu MC, et al
    Emphasis on Harms of Hepatocellular Carcinoma Surveillance: Just Pretending Innocent After Taking Advantages?
    Hepatology. 2017 May 24. doi: 10.1002/hep.29288.
    PubMed     Text format    


  358. CHIANG JYL
    Linking long non-coding RNA to control bile acid signaling and cholestatic liver fibrosis.
    Hepatology. 2017 May 24. doi: 10.1002/hep.29289.
    PubMed     Text format    


  359. MASYUK TV, Masyuk AI, Lorenzo Pisarello M, Howard BN, et al
    TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases via cAMP/Galphas signaling.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29284.
    PubMed     Text format     Abstract available


  360. HAYASHI PH, Rockey D, Fontana RJ, Tillmann HL, et al
    Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29283.
    PubMed     Text format     Abstract available


  361. TSOCHATZIS EA, Bosch J
    Statins in cirrhosis - ready for prime time.
    Hepatology. 2017 May 22. doi: 10.1002/hep.29277.
    PubMed     Text format    


  362. POSSO-OSORIO I, Mendez-Rayo T, Andres Jimenez C, Escobar D, et al
    Hepatic infiltration by silicone in a patient with asia syndrome.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29274.
    PubMed     Text format    


  363. CHO CS, Lombard DB, Lee JH
    SIRT3 as a Regulator of Hepatic Autophagy.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29271.
    PubMed     Text format    


  364. HAN D, Li J, Wang H, Su X, et al
    Circular RNA MTO1 acts as the sponge of miR-9 to suppress hepatocellular carcinoma progression.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29270.
    PubMed     Text format     Abstract available


  365. SAMOYLOVA ML, Nigrini MJ, Dodge JL, Roberts JP, et al
    Biases in the reporting of hcc tumor sizes on the liver transplant waiting list.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29269.
    PubMed     Text format     Abstract available


  366. BUENDIA MA, Armengol C, Cairo S
    Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29262.
    PubMed     Text format    


  367. SAFIRI S, Ayubi E
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis: Methodological issues.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29261.
    PubMed     Text format    


  368. ZHANG QY, Zhao LP, Tian XX, Yan CH, et al
    The novel intracellular protein CREG inhibits hepatic steatosis, obesity and insulin resistance.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29257.
    PubMed     Text format     Abstract available


  369. SLIJEPCEVIC D, Roscam Abbing RLP, Katafuchi T, Blank A, et al
    Hepatic uptake of conjugated bile acids is mediated by both NTCP and OATPs and modulated by intestinal sensing of plasma bile acid levels in mice.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29251.
    PubMed     Text format     Abstract available


  370. DESERT R, Rohart F, Canal F, Sicard M, et al
    Human Hepatocellular Carcinomas with a Periportal Phenotype Have the Lowest Potential for Early Recurrence after Curative Resection.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29254.
    PubMed     Text format     Abstract available


  371. ZHAO E, Ilyas G, Cingolani F, Choi JH, et al
    Pentamidine Blocks Hepatotoxic Injury in Mice.
    Hepatology. 2017 May 3. doi: 10.1002/hep.29244.
    PubMed     Text format     Abstract available


  372. O'HARA SP, LaRusso NF
    Cellular Senescence, Neuropeptides and Hepatic Fibrosis: Additional Insights into Increasing Complexity.
    Hepatology. 2017 May 2. doi: 10.1002/hep.29243.
    PubMed     Text format    


  373. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1429-1431.
    PubMed     Text format    


  374. DULAI PS, Singh S, Patel J, Soni M, et al
    Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
    Hepatology. 2017;65:1557-1565.
    PubMed     Text format     Abstract available


  375. PARK JK, Shao M, Kim MY, Baik SK, et al
    An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization.
    Hepatology. 2017;65:1720-1734.
    PubMed     Text format     Abstract available


  376. XIANG D, Cheng Z, Liu H, Wang X, et al
    Shp2 promotes liver cancer stem cell expansion by augmenting beta-catenin signaling and predicts chemotherapeutic response of patients.
    Hepatology. 2017;65:1566-1580.
    PubMed     Text format     Abstract available


  377. O'HARE EA, Yang R, Yerges-Armstrong LM, Sreenivasan U, et al
    TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
    Hepatology. 2017;65:1526-1542.
    PubMed     Text format     Abstract available


  378. HOU G, Chen L, Liu G, Li L, et al
    Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
    Hepatology. 2017;65:1628-1644.
    PubMed     Text format     Abstract available


  379. RAVA M, D'Andrea A, Doni M, Kress TR, et al
    Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.
    Hepatology. 2017;65:1708-1719.
    PubMed     Text format     Abstract available


  380. WALESKY C, Goessling W
    WNTing no RASt for hepatocellular carcinoma.
    Hepatology. 2017;65:1435-1437.
    PubMed     Text format    


  381. LACKNER C, Bataller R, Burt A, Miquel R, et al
    Fibrosis evaluation by transient elastography in alcoholic liver disease: Is the histological scoring system impacting cutoff values?
    Hepatology. 2017;65:1758-1761.
    PubMed     Text format    


  382. LING Z, Liu X, Cheng Y, Shao L, et al
    Blood microbiota as a potential noninvasive diagnostic biomarker for liver fibrosis in severely obese patients: Choose carefully.
    Hepatology. 2017;65:1775-1776.
    PubMed     Text format    


  383. MARTINEZ J, Tellez L, Albillos A
    Acute variceal bleeding in patients on primary prophylaxis with nonselective beta-blockers: A poor prognosis factor?
    Hepatology. 2017;65:1774.
    PubMed     Text format    


  384. VUPPALANCHI R, Saxena R, Storniolo AMV, Chalasani N, et al
    Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib.
    Hepatology. 2017;65:1762-1764.
    PubMed     Text format    


    April 2017
  385. WON JK, Yu SJ, Hwang CY, Cho SH, et al
    Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.
    Hepatology. 2017 Apr 25. doi: 10.1002/hep.29237.
    PubMed     Text format     Abstract available


  386. ZHENG X, Xu F, Liang H, Cao H, et al
    SIRT1/HSF1/HSPs Pathway is Essential for Exenatide-alleviated Lipid-induced Hepatic Endoplasmic Reticulum Stress.
    Hepatology. 2017 Apr 25. doi: 10.1002/hep.29238.
    PubMed     Text format     Abstract available


  387. SRIVASTAVA J, Robertson CL, Ebeid K, Dozmorov M, et al
    A Novel Role of Astrocyte Elevated Gene-1 (AEG-1) in Regulating Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29230.
    PubMed     Text format     Abstract available


  388. LI S, Dou X, Ning H, Song Q, et al
    SIRT3 Acts As a Negative Regulator of Autophagy Dictating Hepatocyte Susceptibility to Lipotoxicity.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29229.
    PubMed     Text format     Abstract available


  389. KOKUDO T, Hasegawa K, Matsuyama Y, Takayama T, et al
    Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29225.
    PubMed     Text format     Abstract available


  390. BARGE S, Ziol M, Nault JC
    Autoimmune-like chronic hepatitis induced by olmesartan.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29228.
    PubMed     Text format     Abstract available


  391. PEMBROKE T, Sebastiani G
    Hepatic steatosis, hepatitis C and human immunodeficiency viruses: A complex interplay.
    Hepatology. 2017 Apr 19. doi: 10.1002/hep.29218.
    PubMed     Text format    


  392. KUO F, Park J, Chen A
    Coil Assisted Retrograde Transvenous Obliteration and Partial Splenic Artery Embolization for Hepatic Encephalopathy.
    Hepatology. 2017 Apr 13. doi: 10.1002/hep.29212.
    PubMed     Text format    


  393. SONG Y, Liu C, Liu X, Trottier J, et al
    H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of EpCAM.
    Hepatology. 2017 Apr 13. doi: 10.1002/hep.29209.
    PubMed     Text format     Abstract available


  394. LI Y, Song Y, Zhao M, Guo Y, et al
    A Novel Role for CRTC2 in Hepatic Cholesterol Synthesis via SREBP-2.
    Hepatology. 2017 Apr 10. doi: 10.1002/hep.29206.
    PubMed     Text format     Abstract available


  395. ONO A, Goossens N, Finn RS, Schmidt WN, et al
    Persisting risk of hepatocellular carcinoma after HCV cure monitored by a liver transcriptome signature.
    Hepatology. 2017 Apr 8. doi: 10.1002/hep.29203.
    PubMed     Text format    


  396. ZHANG H, Li ZL, Xing H, Wu MC, et al
    Hepatocellular Carcinoma Surveillance: Sometimes Just Specialists' Incidental Behavior?
    Hepatology. 2017 Apr 7. doi: 10.1002/hep.29200.
    PubMed     Text format    


  397. KIM KH, Choi S, Zhou Y, Kim EY, et al
    Hepatic FXR/SHP Axis Modulates Systemic Glucose and Fatty Acid Homeostasis in Aged Mice.
    Hepatology. 2017 Apr 5. doi: 10.1002/hep.29199.
    PubMed     Text format     Abstract available


  398. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1081-1083.
    PubMed     Text format    


  399. HADJIHAMBI A, De Chiara F, Hosford PS, Habtetion A, et al
    Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hepatology. 2017;65:1306-1318.
    PubMed     Text format     Abstract available


  400. BALIGAR P, Kochat V, Arindkar SK, Equbal Z, et al
    Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human alpha1-antitrypsin.
    Hepatology. 2017;65:1319-1335.
    PubMed     Text format     Abstract available


  401. SEBODE M, Weidemann S, Wehmeyer M, Lohse AW, et al
    Anti-TNF-alpha for necrotizing sarcoid granulomatosis of the liver.
    Hepatology. 2017;65:1410-1412.
    PubMed     Text format     Abstract available


  402. MITRA A, Yan J, Xia X, Zhou S, et al
    IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient beta2-spectrin+/- mice.
    Hepatology. 2017;65:1222-1236.
    PubMed     Text format     Abstract available


  403. HALL Z, Bond NJ, Ashmore T, Sanders F, et al
    Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.
    Hepatology. 2017;65:1165-1180.
    PubMed     Text format     Abstract available


  404. PETTA S, Wong VW, Camma C, Hiriart JB, et al
    Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
    Hepatology. 2017;65:1145-1155.
    PubMed     Text format     Abstract available


  405. LO GH
    The interval of endoscopic variceal ligation: The shorter the better?
    Hepatology. 2017;65:1414-1415.
    PubMed     Text format    


  406. SARITAS U, Ustundag Y
    One- or two-week interval for variceal banding after bleeding: Which one to choose?
    Hepatology. 2017;65:1415-1416.
    PubMed     Text format    


  407. SOOKOIAN S, Pirola CJ
    Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention.
    Hepatology. 2017;65:1417-1419.
    PubMed     Text format    


    March 2017
  408. TOHME S, Yazdani HO, Liu Y, Loughran P, et al
    Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth via HMGB1 and TLR9 interaction.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29184.
    PubMed     Text format     Abstract available


  409. LIU P, Ge M, Hu J, Li X, et al
    A functional mTORC1 signaling is indispensable for c-Myc driven hepatocarcinogenesis.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29183.
    PubMed     Text format     Abstract available


  410. SORIA A, Fabbiani M, Lapadula G, Gori A, et al
    Unexpected viral relapses in HCV-infected patients diagnosed with hepatocellular carcinoma during treatment with DAAs.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29181.
    PubMed     Text format    


  411. SORIANO G, Bajaj JS
    Grading the range of hepatic encephalopathy from overt to covert: Animals to the Rescue!
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29186.
    PubMed     Text format    


  412. CHANG FM, Wang YP, Lang HC, Tsai CF, et al
    Statins decrease the risk of decompensation in HBV- and HCV-related cirrhosis: A population-based study.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29172.
    PubMed     Text format     Abstract available


  413. SASAKI R, Devhare PB, Steele R, Ray R, et al
    Hepatitis C virus induced CCL5 secretion from macrophages activates hepatic stellate cells.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29170.
    PubMed     Text format     Abstract available


  414. NAHON P, Seror O, Durand-Zaleski I
    Reply to: <<Screening for Hepatocellular carcinoma: A drug safety issue>>.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29174.
    PubMed     Text format    


  415. BRAILLON A
    Screening for hepatocellular carcinoma: A drug safety issue.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29173.
    PubMed     Text format    


  416. DE MATTOS AZ, Miozzo SA, Tovo CV, de Mattos AA, et al
    Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29132.
    PubMed     Text format    


  417. MOLLER S, Hove JD
    Assessment of systolic function in the evaluation of patients with cirrhosis.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29163.
    PubMed     Text format    


  418. SINCLAIR M, Schelleman A, Sandhu D, Angus PW, et al
    Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29151.
    PubMed     Text format     Abstract available


  419. YANG Y, Zhou Y, Hou J, Bai C, et al
    Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29156.
    PubMed     Text format     Abstract available


  420. HE Y, Feng D, Li M, Gao Y, et al
    Hepatic mtDNA-TLR9-microRNA-223 forms a negative feedback loop to limit neutrophil over-activation and acetaminophen hepatotoxicity.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29153.
    PubMed     Text format     Abstract available


  421. FLORIMONTE L, Iavarone M, Castellani M, Longo M, et al
    Uncommon extrahepatic metastases from hepatocellular carcinoma.
    Hepatology. 2017 Mar 10. doi: 10.1002/hep.29147.
    PubMed     Text format    


  422. WANG L, Zhang W, Ge CH, Yin RH, et al
    TLR5 signaling restrains T/NKT cell activation and protects against concanavalin A-induced hepatic injury.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29140.
    PubMed     Text format     Abstract available


  423. CAMPAGNA F, Montagnese S, Ridola L, Senzolo M, et al
    The animal naming test: An easy tool for the assessment of hepatic encephalopathy.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29146.
    PubMed     Text format     Abstract available


  424. LI X, Liu R, Yang J, Sun L, et al
    The role of LncRNA H19 in gender disparity of cholestatic liver injury in Mdr2-/- mice.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29145.
    PubMed     Text format     Abstract available


  425. WAN Y, Meng F, Wu N, Zhou T, et al
    Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29138.
    PubMed     Text format     Abstract available


  426. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:761-762.
    PubMed     Text format    


  427. MAIERS JL, Kostallari E, Mushref M, deAssuncao TM, et al
    The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice.
    Hepatology. 2017;65:983-998.
    PubMed     Text format     Abstract available


  428. ZHU B, Wei L, Rotile N, Day H, et al
    Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model.
    Hepatology. 2017;65:1015-1025.
    PubMed     Text format     Abstract available


  429. ALONSO EM, Horslen SP, Behrens EM, Doo E, et al
    Pediatric acute liver failure of undetermined cause: A research workshop.
    Hepatology. 2017;65:1026-1037.
    PubMed     Text format     Abstract available


  430. KISSELEVA T
    The origin of fibrogenic myofibroblasts in fibrotic liver.
    Hepatology. 2017;65:1039-1043.
    PubMed     Text format     Abstract available


  431. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
    Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.
    Hepatology. 2017;65:938-949.
    PubMed     Text format     Abstract available


  432. MUSSO G, Cassader M, Paschetta E, Gambino R, et al
    Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: New evidence, new challenges.
    Hepatology. 2017;65:1058-1061.
    PubMed     Text format    


  433. ESHRAGHIAN A
    High prevalence of nonalcoholic fatty liver disease in the middle east: Lifestyle and dietary habits.
    Hepatology. 2017;65:1077.
    PubMed     Text format    


    February 2017
  434. FAN Z, Li L, Li M, Zhang X, et al
    The histone methyltransferase Suv39h2 contributes to non-alcoholic steatohepatitis in mice.
    Hepatology. 2017 Feb 28. doi: 10.1002/hep.29127.
    PubMed     Text format     Abstract available


  435. YAN F, Wang Y, Zhang W, Chang M, et al
    Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection.
    Hepatology. 2017 Feb 25. doi: 10.1002/hep.29134.
    PubMed     Text format     Abstract available


  436. DAM G, Vilstrup H, Watson H, Jepsen P, et al
    Reply to letter from de Mattos and colleagues: Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Feb 21. doi: 10.1002/hep.29131.
    PubMed     Text format    


  437. WANG W, Xu MJ, Cai Y, Zhou Z, et al
    Inflammation is independent of steatosis in a murine model of steatohepatitis.
    Hepatology. 2017 Feb 21. doi: 10.1002/hep.29129.
    PubMed     Text format     Abstract available


  438. SABERI B, Dadabhai AS, Durand CM, Philosophe B, et al
    Challenges in Treatment of Hepatitis C among Patients with Hepatocellular Carcinoma.
    Hepatology. 2017 Feb 17. doi: 10.1002/hep.29126.
    PubMed     Text format    


  439. LI H, Zhou ZQ, Yang ZR, Tong DN, et al
    MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Hepatology. 2017 Feb 14. doi: 10.1002/hep.29116.
    PubMed     Text format     Abstract available


  440. LEMPP FA, Wiedtke E, Qu B, Roques P, et al
    Sodium taurocholate cotransporting polypeptide is the limiting host factor of Hepatitis B Virus infection in macaque and pig hepatocytes.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29112.
    PubMed     Text format     Abstract available


  441. BRUDEN DJ, McMahon BJ, Townshend-Bulson L, Gounder P, et al
    Risk of End Stage Liver Disease, Hepatocellular Carcinoma and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29115.
    PubMed     Text format     Abstract available


  442. WANG H, An P, Xie E, Wu Q, et al
    Characterization of Ferroptosis in Murine Models of Hemochromatosis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29117.
    PubMed     Text format     Abstract available


  443. GOLDEN-MASON L, Rosen HR
    Galectin-9: Diverse Roles in Hepatic Immune Homeostasis and Inflammation.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29106.
    PubMed     Text format     Abstract available


  444. IWAKIRI Y
    Reply to the Letter to the Editor in regards to the commentary on "The lymphatic system: A new frontier in hepatology".
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29102.
    PubMed     Text format    


  445. YOTTI R, Ripoll C, Benito Y, Catalina MV, et al
    Left ventricular systolic function is associated to sympathetic nervous activity and markers of inflammation in cirrhosis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29104.
    PubMed     Text format     Abstract available


  446. GOLDSWORTHY MA, Rowe IA
    Patient understanding of hepatocellular carcinoma surveillance.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29103.
    PubMed     Text format    


  447. KUMAR A, Davuluri G, deSilva RN, Engelen MP, et al
    Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29107.
    PubMed     Text format    


  448. KRAWCZYK M, Rau M, Grunhage F, Schattenberg JM, et al
    The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.29100.
    PubMed     Text format    


  449. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Text format     Abstract available


  450. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Text format     Abstract available


  451. FERNANDEZ CARRILLO C, Lens S, Llop E, Pascasio JM, et al
    Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of MELD: Analysis of data from the Hepa-C registry.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29097.
    PubMed     Text format     Abstract available


  452. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:399-400.
    PubMed     Text format    


  453. ZUBIETE-FRANCO I, Fernandez-Tussy P, Barbier-Torres L, Simon J, et al
    Deregulated neddylation in liver fibrosis.
    Hepatology. 2017;65:694-709.
    PubMed     Text format     Abstract available


  454. KAIKKONEN JE, Wurtz P, Suomela E, Lehtovirta M, et al
    Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study.
    Hepatology. 2017;65:491-500.
    PubMed     Text format     Abstract available


  455. GOLDRING C, Antoine DJ, Bonner F, Crozier J, et al
    Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.
    Hepatology. 2017;65:710-721.
    PubMed     Text format     Abstract available


  456. HU H, Zhu W, Qin J, Chen M, et al
    Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis.
    Hepatology. 2017;65:515-528.
    PubMed     Text format     Abstract available


  457. MA JZ, Yang F, Zhou CC, Liu F, et al
    METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary MicroRNA processing.
    Hepatology. 2017;65:529-543.
    PubMed     Text format     Abstract available


  458. DEL CHIERICO F, Nobili V, Vernocchi P, Russo A, et al
    Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
    Hepatology. 2017;65:451-464.
    PubMed     Text format     Abstract available


  459. HATTING M, Tacke F
    From NAFLD to HCC: Is IL-17 the crucial link?
    Hepatology. 2017;65:739-741.
    PubMed     Text format    


  460. SINTUSEK P, Dhawan A
    Lipid and copper metabolism in humans with wilson disease: Enigmatic relationship.
    Hepatology. 2017;65:753-755.
    PubMed     Text format    


  461. THIELE M, Madsen BS, Krag A
    Is liver stiffness equal to liver fibrosis?
    Hepatology. 2017;65:749.
    PubMed     Text format    


    January 2017
  462. VILASECA M, Garcia-Caldero H, Lafoz E, Garcia-Irigoyen O, et al
    The anticoagulant Rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
    Hepatology. 2017 Jan 31. doi: 10.1002/hep.29084.
    PubMed     Text format     Abstract available


  463. WANG Y, Vincent R, Yang J, Asgharpour A, et al
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29090.
    PubMed     Text format     Abstract available


  464. VON LOEFFELHOLZ C, Lieske S, Neuschafer-Rube F, Willmes DM, et al
    The Human Longevity Gene Homolog INDY and Interleukin-6 Interact in Hepatic Lipid Metabolism.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29089.
    PubMed     Text format     Abstract available


  465. GORDON-WEEKS AN, Lim SY, Yuzhalin AE, Jones K, et al
    Neutrophils Promote Hepatic Metastasis Growth Through fibroblast growth factor (FGF)2-dependent Angiogenesis.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29088.
    PubMed     Text format     Abstract available


  466. HEIMBACH J, Kulik LM, Finn R, Sirlin CB, et al
    Aasld guidelines for the treatment of hepatocellular carcinoma.
    Hepatology. 2017 Jan 28. doi: 10.1002/hep.29086.
    PubMed     Text format    


  467. SHIMIZU Y, Peltzer N, Sevko A, Lafont E, et al
    The linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29074.
    PubMed     Text format     Abstract available


  468. HARGROVE L, Kennedy L, Demieville J, Jones H, et al
    BDL-induced biliary hyperplasia, hepatic injury and fibrosis are reduced in mast cell deficient Kitw-sh mice.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29079.
    PubMed     Text format     Abstract available


  469. WANG Y, Aoki H, Yang J, Peng K, et al
    The role of S1PR2 in bile acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29076.
    PubMed     Text format     Abstract available


  470. STEINMETZ C, Kashyap A, Zhivkova N, Alizor H, et al
    Activation of SIRT1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammation.
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29072.
    PubMed     Text format     Abstract available


  471. SABATE A, Blasi A
    Thromboelastography and blood product usage in cirrhosis with severe coagulopathy.
    Hepatology. 2017 Jan 19. doi: 10.1002/hep.29061.
    PubMed     Text format    


  472. VILLANUEVA C, Graupera I, Aracil C, Alvarado E, et al
    A Randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Hepatology. 2017 Jan 18. doi: 10.1002/hep.29056.
    PubMed     Text format     Abstract available


  473. DRIVER R, Rowe IA
    What is the benefit of early follow-up after hospitalization for patients with cirrhosis?
    Hepatology. 2017 Jan 18. doi: 10.1002/hep.29060.
    PubMed     Text format    


  474. ARORA P, Basu A, Schmidt ML, Clark GJ, et al
    NS5B Promotes Degradation of the NORE1A Tumor Suppressor to Facilitate Hepatitis C Virus Replication.
    Hepatology. 2017 Jan 16. doi: 10.1002/hep.29049.
    PubMed     Text format     Abstract available


  475. JOO EJ, Chang Y, Ryu S
    Response to NAFLD, hepatotropic viruses and cardio-metabolic risk.
    Hepatology. 2017 Jan 13. doi: 10.1002/hep.29048.
    PubMed     Text format    


  476. LONARDO A, Nascimbeni F, Ballestri S
    NAFLD, hepatotropic viruses and cardio-metabolic risk.
    Hepatology. 2017 Jan 13. doi: 10.1002/hep.29052.
    PubMed     Text format    


  477. LIN L, Ding Y, Wang Y, Wang Z, et al
    Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29033.
    PubMed     Text format     Abstract available


  478. ATANASOVSKA B, Rensen SS, van der Sijde MR, Marsman G, et al
    A liver-specific long non-coding RNA with a role in cell viability is elevated in human non-alcoholic steatohepatitis.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29034.
    PubMed     Text format     Abstract available


  479. JANG JE, Park HS, Yoo HJ, Baek IJ, et al
    Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29039.
    PubMed     Text format     Abstract available


  480. LEFERE S, Hoorens A, Raevens S, Troisi R, et al
    Refractory subacute steatohepatitis after biliopancreatic diversion.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29038.
    PubMed     Text format     Abstract available


  481. BRUSCHI FV, Claudel T, Tardelli M, Caligiuri A, et al
    The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29041.
    PubMed     Text format     Abstract available


  482. PASTORE N, Attanasio S, Granese B, Teckman J, et al
    Activation of JNK pathway aggravates proteotoxicity of hepatic mutant Z alpha1-antitrypsin.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29035.
    PubMed     Text format     Abstract available


  483. YUE X, Ai J, Xu Y, Chen Y, et al
    Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29036.
    PubMed     Text format     Abstract available


  484. ALKHOURI N, Feldstein AE
    Treating Nonalcoholic Steatohepatitis (NASH) in Children: Not a Cinch Task.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29043.
    PubMed     Text format     Abstract available


  485. STRAZZABOSCO M, Allen JI, Teisberg EO
    Value based care in hepatology.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29042.
    PubMed     Text format     Abstract available


  486. BJORNSSON ES, Jonasson JG
    Idiosyncratic drug-induced liver injury associated with bile duct loss and vanishing bile duct syndrome: Rare but has severe consequences.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29040.
    PubMed     Text format    


  487. VARRASSO G, Schiavetti A, Lanciotti S, Sapio M, et al
    Propranolol as First Line Treatment for Life-threatening Diffuse Infantile Hepatic Hemangioma: A Case Report.
    Hepatology. 2017 Jan 5. doi: 10.1002/hep.29028.
    PubMed     Text format    


  488. MARONI L, Hohenester SD, van de Graaf SF, Tolenaars D, et al
    Knockout of the Primary Sclerosing Cholangitis-Risk Gene Fut2 Causes Liver Disease in Mice.
    Hepatology. 2017 Jan 5. doi: 10.1002/hep.29029.
    PubMed     Text format     Abstract available


  489. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1-3.
    PubMed     Text format    


  490. ALCARAZ-QUILES J, Titos E, Casulleras M, Pavesi M, et al
    Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure.
    Hepatology. 2017;65:202-216.
    PubMed     Text format     Abstract available


  491. DECARIS ML, Li KW, Emson CL, Gatmaitan M, et al
    Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.
    Hepatology. 2017;65:78-88.
    PubMed     Text format     Abstract available


  492. NAVARRO VJ, Khan I, Bjornsson E, Seeff LB, et al
    Liver injury from herbal and dietary supplements.
    Hepatology. 2017;65:363-373.
    PubMed     Text format     Abstract available


  493. WANG J, Koh HW, Zhou L, Bae UJ, et al
    Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen-activated protein kinase phosphatase-1.
    Hepatology. 2017;65:225-236.
    PubMed     Text format     Abstract available


  494. AJMERA V, Perito ER, Bass NM, Terrault NA, et al
    Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.
    Hepatology. 2017;65:65-77.
    PubMed     Text format     Abstract available


  495. LEUNG JC, Loong TC, Wei JL, Wong GL, et al
    Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.
    Hepatology. 2017;65:54-64.
    PubMed     Text format     Abstract available


  496. MEDINA-CALIZ I, Robles-Diaz M, Lucena MI, Andrade RJ, et al
    Drug-induced liver and skin reactions: In need of a consensus definition.
    Hepatology. 2017;65:391.
    PubMed     Text format    


  497. LIU K, Xu W, Wong VW
    Serum biomarkers for nonalcoholic fatty liver disease: Are we there yet?
    Hepatology. 2017;65:8-11.
    PubMed     Text format    


  498. LO GH
    The use of esophageal stent in controlling acute refractory variceal bleeding.
    Hepatology. 2017;65:385-386.
    PubMed     Text format    


    December 2016
  499. SHUNG DL, Garcia-Tsao G
    Liver Capsule: Portal Hypertension and Varices: Pathogenesis, Stages and Management.
    Hepatology. 2016 Dec 29. doi: 10.1002/hep.29026.
    PubMed     Text format    


  500. LI N, Zhou ZS, Shen Y, Xu J, et al
    Inhibition of the SREBP pathway suppresses hepatocellular carcinoma through repressing inflammation.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29018.
    PubMed     Text format     Abstract available


  501. MCCOMMIS KS, Hodges WT, Brunt EM, Nalbantoglu I, et al
    Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29025.
    PubMed     Text format     Abstract available


  502. LI D, Liu X, Zhou J, Hu J, et al
    LncRNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of ERK and YB-1 to enhance hepatocarcinogenesis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29010.
    PubMed     Text format     Abstract available


  503. TANDON P, Raman M, Mourtzakis M, Merli M, et al
    A Practical Approach to Nutritional Screening and Assessment in Cirrhosis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29003.
    PubMed     Text format     Abstract available


  504. HAUSSINGER D, Keitel V
    Dual role of the bile acid receptor TGR5 for hepatic lipid metabolism in feast and famine.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29017.
    PubMed     Text format    


  505. WANG KS, Tiao G, Bass LM, Hertel PM, et al
    Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29019.
    PubMed     Text format     Abstract available


  506. QIU YL, Gong JY, Feng JY, Wang RX, et al
    Defects in MYO5B are associated with a spectrum of previously undiagnosed low gamma-glutamyltransferase cholestasis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29020.
    PubMed     Text format     Abstract available


  507. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.
    PubMed     Text format    


  508. AYUBI E, Safiri S, Sani M, Doosti-Irani A, et al
    Effect of Metabolic syndrome on cardiovascular, hepatic events and death in CHB patients: Methodological issues.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.29001.
    PubMed     Text format    


  509. BERZIGOTTI A, Albillos A, Villanueva C, Genesca J, et al
    Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The sportdiet study.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28992.
    PubMed     Text format     Abstract available


  510. MICHALOPOULOS GK
    Hepatostat: Liver regeneration and normal liver tissue maintenance.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28988.
    PubMed     Text format     Abstract available


  511. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.
    PubMed     Text format    


  512. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.
    PubMed     Text format    


  513. MORIS D, Felekouras E
    Ignore reality but not the consequences of its ignorance: Broaden Guidelines in surgery of Hepatocellular carcinoma.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28984.
    PubMed     Text format     Abstract available


  514. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Text format     Abstract available


  515. TAO J, Zhang R, Singh S, Poddar M, et al
    Targeting beta-catenin in hepatocellular cancers induced by co-expression of mutant beta-catenin and K-Ras in mice.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28975.
    PubMed     Text format     Abstract available


  516. BRIL F, Barb D, Portillo-Sanchez P, Biernacki D, et al
    Metabolic and Histological Implications of Intrahepatic Triglyceride Content in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28985.
    PubMed     Text format     Abstract available


  517. MORZYGLOD L, Cauzac M, Popineau L, Denechaud PD, et al
    Grb14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28972.
    PubMed     Text format     Abstract available


  518. YAN FJ, Zhang XJ, Wang WX, Ji YX, et al
    The E3 ligase TRIM8 targets TAK1 to promote insulin resistance and steatohepatitis.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28971.
    PubMed     Text format     Abstract available


  519. KAFFE E, Katsifa A, Xylourgidis N, Ninou I, et al
    Hepatocyte Autotaxin expression promotes liver fibrosis and cancer.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28973.
    PubMed     Text format     Abstract available


  520. BUSCH CJ, Hendrikx T, Weismann D, Jackel S, et al
    Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28970.
    PubMed     Text format     Abstract available


  521. FAN W, Yang H, Liu T, Wang J, et al
    Prohibitin 1 Suppresses Liver Cancers Tumorigenesis in Mice and Human Hepatocellular and Cholangiocarcinoma cells.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28964.
    PubMed     Text format     Abstract available


  522. PRICE JC, Ma Y, Scherzer R, Korn N, et al
    HIV-infected and Uninfected Adults with Non-Genotype 3 Hepatitis C Virus Have Less Hepatic Steatosis than Adults with Neither Infection.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28968.
    PubMed     Text format     Abstract available


  523. BONKOVSKY HL, Kleiner DE, Gu J, Odin JA, et al
    Clinical Presentations and Outcomes of Bile Duct Loss caused by Drugs and Herbal and Dietary Supplements.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28967.
    PubMed     Text format     Abstract available


  524. JANSEN PL, Ghallab A, Vartak N, Reif R, et al
    The ascending pathophysiology of cholestatic liver disease.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28965.
    PubMed     Text format     Abstract available


  525. TAHARA Y, Shibata S
    Abnormal tuning of the hepatic circadian metabolic rhythms in lung cancer.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28982.
    PubMed     Text format    


  526. HERNAEZ R, El-Serag H, DeBakey ME
    Hepatocellular Carcinoma Surveillance: The Road Ahead.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28983.
    PubMed     Text format    



  527. 2016 Hepatology referees (volumes 63 and 64).
    Hepatology. 2016;64:2280-2285.
    PubMed     Text format    


  528. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1829-1830.
    PubMed     Text format    


    November 2016
  529. VALDECANTOS MP, Pardo V, Ruiz L, Castro-Sanchez L, et al
    A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28962.
    PubMed     Text format     Abstract available


  530. KLEBANOFF MJ, Corey KE, Chhatwal J, Kaplan LM, et al
    Bariatric Surgery for Nonalcoholic Steatohepatitis: A Clinical and Cost-Effectiveness Analysis.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28958.
    PubMed     Text format     Abstract available


  531. TRAN M, Wang L
    Preserving LXR by Inhibiting T39: A step closer to treating atherosclerosis and steatohepatitis?
    Hepatology. 2016 Nov 17. doi: 10.1002/hep.28946.
    PubMed     Text format    


  532. ASKGAARD G, Leon DA, Kjaer MS, Deleuran T, et al
    Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study.
    Hepatology. 2016 Nov 16. doi: 10.1002/hep.28943.
    PubMed     Text format     Abstract available


  533. NEWBERRY EP, Xie Y, Kennedy SM, Graham MJ, et al
    Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in Liver fatty acid binding protein null mice.
    Hepatology. 2016 Nov 14. doi: 10.1002/hep.28941.
    PubMed     Text format     Abstract available


  534. VAN ASTEN M, Verhaegh P, Koek G, Verbeek J, et al
    The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care.
    Hepatology. 2016 Nov 10. doi: 10.1002/hep.28940.
    PubMed     Text format    


  535. CALDWELL S, Lisman T
    The cirrhotic platelet: Shedding light on an enigma.
    Hepatology. 2016 Nov 7. doi: 10.1002/hep.28931.
    PubMed     Text format    


  536. KIM JH, Sinn DH, Kang W, Gwak GY, et al
    Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28916.
    PubMed     Text format     Abstract available


  537. YAN S, Tang J, Zhang Y, Wang Y, et al
    Prostaglandin E2 promotes hepatic bile acid synthesis by an E prostanoid receptor 3-mediated hepatocyte nuclear receptor 4alpha/cholesterol 7alpha-hydroxylase pathway in mice.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28928.
    PubMed     Text format     Abstract available


  538. MASSEY VL, Dolin CE, Poole LG, Hudson SV, et al
    The hepatic "matrisome" responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28918.
    PubMed     Text format     Abstract available


  539. NIU Y, Xu M, Slagle BL, Huang H, et al
    Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28924.
    PubMed     Text format     Abstract available


  540. DESBOROUGH MJ, Kahan BC, Stanworth SJ, Jairath V, et al
    Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding.
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28915.
    PubMed     Text format    


  541. DROLZ A, Fuhrmann V
    "Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding".
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28914.
    PubMed     Text format    


  542. CAI WY, Lin LY, Hao H, Zhang SM, et al
    YAP-TEAD and HNF4alpha repress reciprocally to regulate hepatocarcinogenesis.
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28911.
    PubMed     Text format     Abstract available


  543. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1395-1397.
    PubMed     Text format    


  544. QURESHI MA, Kim YO, Schuppan D
    Hepatocellular carcinoma in nonalcoholic fatty liver disease: A link between oxidative stress and T-cell suppression.
    Hepatology. 2016;64:1794-1797.
    PubMed     Text format    


  545. TAO J, Xu E, Zhao Y, Singh S, et al
    Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant beta-catenin.
    Hepatology. 2016;64:1587-1605.
    PubMed     Text format     Abstract available


    October 2016
  546. GARCIA-TSAO G, Abraldes J, Berzigotti A, Bosch J, et al
    Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis and Management - 2016 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2016 Oct 27. doi: 10.1002/hep.28906.
    PubMed     Text format    


  547. KALAFATELI M, Wickham F, Burniston M, Cholongitas E, et al
    Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
    Hepatology. 2016 Oct 25. doi: 10.1002/hep.28891.
    PubMed     Text format     Abstract available


  548. TANDON P, Reddy KR, O'Leary JG, Garcia-Tsao G, et al
    A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28900.
    PubMed     Text format     Abstract available


  549. ATIQ O, Tiro J, Yopp AC, Muffler A, et al
    An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28895.
    PubMed     Text format     Abstract available


  550. SUMAZIN P, Chen Y, Trevino LR, Sarabia SF, et al
    Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28888.
    PubMed     Text format     Abstract available


  551. KIMER N, Pedersen JS, Busk TM, Gluud LL, et al
    Rifaximin has no effect on hemodynamics in decompensated cirrhosis - A randomized, double blind, placebo controlled trial.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28898.
    PubMed     Text format     Abstract available


  552. SUN Q, Loughran P, Shapiro R, Shrivastava IH, et al
    Redox-dependent regulation of hepatocyte AIM2 inflammasome activation in sterile liver injury in mice.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28893.
    PubMed     Text format     Abstract available


  553. KE S, Chen S, Dong Z, Hong CS, et al
    Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28889.
    PubMed     Text format     Abstract available


  554. LABONTE AC, Sung SJ, Jennelle LT, Dandekar AP, et al
    Expression of scavenger receptor-AI promotes alternative activation of murine macrophages to limit hepatic inflammation and fibrosis.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28873.
    PubMed     Text format     Abstract available


  555. PARIKH ND, Marshall VD, Singal AG, Nathan H, et al
    Survival and Cost-Effectiveness of Sorafenib Therapy in Advanced Hepatocellular Carcinoma: An Analysis of the SEER-Medicare Database.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28881.
    PubMed     Text format     Abstract available


  556. GARCIA-TSAO G
    Empowering Women - Perspective from a Hepatologist.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28875.
    PubMed     Text format    


  557. BERGMANN J, Muller M, Baumann N, Reichert M, et al
    IL-6 trans-signaling is essential for the development of hepatocellular carcinoma.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28874.
    PubMed     Text format     Abstract available


  558. MAROT A, Vandenbulcke H, Knebel JF, Doerig C, et al
    External validation of the nomogram for individualized prediction of HCC occurrence in patients with HCV-related compensated cirrhosis.
    Hepatology. 2016 Oct 13. doi: 10.1002/hep.28865.
    PubMed     Text format    


  559. HASLAM DB
    Non-alcoholic steatohepatitis and the intestinal microbiota.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28864.
    PubMed     Text format    


  560. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1011-3.
    PubMed     Text format    


    September 2016
  561. ALI KHAN M, Cholankeril G, Howden CW
    Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast.
    Hepatology. 2016 Sep 30. doi: 10.1002/hep.28858.
    PubMed     Text format    


  562. LAINE F, Ruivard M, Loustaud-Ratti V, Bonnet F, et al
    Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
    Hepatology. 2016 Sep 29. doi: 10.1002/hep.28856.
    PubMed     Text format     Abstract available


  563. CHENG JY, Wong VW, Tse YK, Chim AM, et al
    Metabolic syndrome increases cardiovascular event but not hepatic event and death in patients with chronic hepatitis B.
    Hepatology. 2016 Sep 29. doi: 10.1002/hep.28778.
    PubMed     Text format     Abstract available


  564. PONZETTO A, Srinivasan RS
    Risk factors for hepatocellular carcinoma.
    Hepatology. 2016 Sep 28. doi: 10.1002/hep.28854.
    PubMed     Text format    


  565. LO GH
    The risk of bleeding after invasive procedures in cirrhotics with severe coagulopathy.
    Hepatology. 2016 Sep 26. doi: 10.1002/hep.28855.
    PubMed     Text format    


  566. CUSI K
    Nonalcoholic Steatohepatitis in Non-Obese Patients: Not So Different After All.
    Hepatology. 2016 Sep 20. doi: 10.1002/hep.28839.
    PubMed     Text format    


  567. RAPARELLI V, Basili S, Carnevale R, Napoleone L, et al
    Low-grade endotoxemia and platelet activation in cirrhosis.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28853.
    PubMed     Text format     Abstract available


  568. LI D, Li W, Hui L
    Hybrid hepatocyte: A newly identified player for regeneration in hepatic injuries.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28837.
    PubMed     Text format     Abstract available


  569. MULLIGAN DC
    The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28841.
    PubMed     Text format    


  570. AMARAPURKAR D, Somani V, Shah A
    Do we need to correct coagulation abnormalities prophylactically in cirrhotics undergoing invasive procedures? - A Dilemma.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28830.
    PubMed     Text format    


  571. EGUCHI A, Lazaro RG, Wang J, Kim J, et al
    Extracellular vesicles released by hepatocytes from gastric infusion model of ALD contain a miRNA barcode that can be detected in blood.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28838.
    PubMed     Text format     Abstract available


  572. GASTALDELLI A, Gaggini M, Daniele G, Ciociaro D, et al
    Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic PET study.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28827.
    PubMed     Text format     Abstract available


  573. ABRALDES JG, Bureau C, Stefanescu H, Augustin S, et al
    Non-invasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28824.
    PubMed     Text format     Abstract available


  574. AZZARITI A, Mancarella S, Porcelli L, Elisa Quatrale A, et al
    Hepatic Stellate Cells Induce HCC Cell Resistance to Sorafenib through the Laminin-332/alpha3 Integrin Axis recovery of FAK Ubiquitination.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28835.
    PubMed     Text format     Abstract available


  575. KULKARNI SR, Soroka CJ, Hagey LR, Boyer JL, et al
    Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid fed mouse model of cholestasis.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28826.
    PubMed     Text format     Abstract available


  576. TANAKA S, Hikita H, Tatsumi T, Sakamori R, et al
    Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease.
    Hepatology. 2016 Sep 16. doi: 10.1002/hep.28820.
    PubMed     Text format     Abstract available


  577. KAMINSKY P, Preiss J, Sasatomi E, Gerber DA, et al
    Biliary Adenofibroma: A Rare Hepatic Lesion with Malignant Features.
    Hepatology. 2016 Sep 15. doi: 10.1002/hep.28818.
    PubMed     Text format    


  578. RUSSO MW, Koteish A, Fuchs M, Reddy G, et al
    Workforce in Hepatology: Update and a critical need for more information.
    Hepatology. 2016 Sep 15. doi: 10.1002/hep.28810.
    PubMed     Text format     Abstract available


  579. HO CM, Chen HL
    Expression of Glutamine Synthetase in Hepatocyte Progenitor Cells Derived from Canal of Hering.
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28805.
    PubMed     Text format    


  580. TREVISANI F, Bucci L, Garuti F
    Is it time to extend criteria for hepatic resection in the treatment of hepatocellular carcinoma?
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28804.
    PubMed     Text format    


  581. SOLINAS A, Calvisi DF
    PD-L1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer?
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28803.
    PubMed     Text format    


  582. RENOU C, Lesgourgues B, Macaigne G, Pauwels A, et al
    Hepatitis E in decompensated alcoholic cirrhosis.
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28792.
    PubMed     Text format    


  583. PASCALE RM, Feo F, Calvisi DF
    An infernal crosstalk between oncogenic beta-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling.
    Hepatology. 2016 Sep 6. doi: 10.1002/hep.28790.
    PubMed     Text format    


  584. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:703-5.
    PubMed     Text format    


    August 2016
  585. TORNER A, Stokkeland K, Svensson A, Dickman PW, et al
    The underreporting of hepatocellular carcinoma to the Cancer Register and a log-linear model to estimate a more correct incidence.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28775.
    PubMed     Text format     Abstract available


  586. OKABE H, Yang J, Sylakowski K, Yovchev M, et al
    Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28774.
    PubMed     Text format     Abstract available


  587. LAUSCHKE VM, Vorrink SU, Moro SM, Reyazee F, et al
    Massive rearrangements of cellular miRNA signatures are key drivers of hepatocyte dedifferentiation.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28780.
    PubMed     Text format     Abstract available


  588. LALEMAN W, Trebicka J, Verbeke L
    Evolving insights in the pathophysiology of complications of cirrhosis: The Farnesoid-X receptor (FXR) to the rescue?
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28771.
    PubMed     Text format    


  589. FARVARDIN S, Patel J, Khambaty M, Yerokun OA, et al
    Patient-Reported Barriers are Associated with Lower HCC Surveillance Rates in Patients with Cirrhosis.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28770.
    PubMed     Text format     Abstract available


  590. SALLOUM S, Holmes JA, Jindal R, Bale SS, et al
    HIV/HCV in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28766.
    PubMed     Text format     Abstract available


  591. GOLDBERG DS, Taddei TH, Serper M, Mehta R, et al
    Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28765.
    PubMed     Text format     Abstract available


  592. CHEN HA, Kuo TC, Tseng CF, Ma JT, et al
    ANGPTL1 Antagonizes MET Receptor Activity to Repress Sorafenib Resistance and Cancer Stemness in Hepatocellular Carcinoma Cells.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28773.
    PubMed     Text format     Abstract available


  593. GONZALES E, Taylor SA, Davit-Spraul A, Thebaut A, et al
    MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28779.
    PubMed     Text format     Abstract available


  594. CLERBAUX LA, Manco R, Leclercq I
    Upstream regulators of hepatic Wnt/beta-catenin activity control liver metabolic zonation, development and regeneration.
    Hepatology. 2016 Aug 12. doi: 10.1002/hep.28763.
    PubMed     Text format    


  595. MIKOLAJCZYK AE, Farnan JM, McConville JF, Jensen DM, et al
    Novel Educational Interventions in Residency Increase Knowledge of Chronic Liver Disease and Career Interest in Hepatology.
    Hepatology. 2016 Aug 10. doi: 10.1002/hep.28741.
    PubMed     Text format     Abstract available


  596. BIHARI C, Anand L, Rooge S, Kumar D, et al
    Bone Marrow Stem Cells and its Niche Components are Adversely Affected in Advanced Cirrhosis of Liver.
    Hepatology. 2016 Aug 3. doi: 10.1002/hep.28754.
    PubMed     Text format     Abstract available


  597. CLARIA J, Stauber RE, Coenraad MJ, Moreau R, et al
    systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28740.
    PubMed     Text format     Abstract available


  598. DROLZ A, Fuhrmann V
    Reply to "Anticoagulation with i.v. unfractionated heparin and major bleeding in cirrhosis".
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28757.
    PubMed     Text format    


  599. SAPISOCHIN G, Facciuto M, Rubbia-Brandt L, Marti J, et al
    Liver transplantation for "very early" intrahepatic cholangiocarcinoma. international retrospective study supporting a prospective assessment.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28744.
    PubMed     Text format     Abstract available


  600. HU W, Zhang W, Chen Y, Rana U, et al
    Nogo-B receptor deficiency increases LXRalpha nuclear translocation and hepatic lipogenesis via an AMPKalpha-dependent pathway.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28747.
    PubMed     Text format     Abstract available



  601. Correction: Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes.
    Hepatology. 2016;64:702.
    PubMed     Text format    


  602. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:325-7.
    PubMed     Text format    


    July 2016
  603. QI X, De Stefano V, Guo X
    Anticoagulation with i.v. unfractionated heparin and major bleeding in cirrhosis.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28743.
    PubMed     Text format    


  604. DAM G, Vilstrup H, Watson H, Jepsen P, et al
    Proton Pump Inhibitors as a Risk Factor for Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis in Cirrhosis Patients With Ascites.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28737.
    PubMed     Text format     Abstract available


  605. LI L, Piontek K, Ishida M, Fausther M, et al
    Extracellular vesicles carry miR-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28735.
    PubMed     Text format     Abstract available


  606. MAROT A, Trepo E, Doerig C, Moreno C, et al
    SEMS should be considered in patients with cirrhosis and uncontrolled variceal bleeding.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28738.
    PubMed     Text format    


  607. DUNCAN SA
    Multipotent stem cells and their lineage restriction to hepatocytes.
    Hepatology. 2016 Jul 12. doi: 10.1002/hep.28727.
    PubMed     Text format    


  608. SUGIYAMA M, Kanto T
    Dual blockade of HCV entry at a gatekeeper of hepatocytes - Not only a preventive but also therapeutic target of CLDN-1.
    Hepatology. 2016 Jul 12. doi: 10.1002/hep.28726.
    PubMed     Text format    


  609. PORAT-SHLIOM N, Tietgens AJ, Van Itallie CM, Vitale-Cross L, et al
    Liver Kinase B1 regulates hepatocellular tight junction distribution and function in vivo.
    Hepatology. 2016 Jul 11. doi: 10.1002/hep.28724.
    PubMed     Text format     Abstract available


  610. KOPPE C, Verheugd P, Gautheron J, Reisinger F, et al
    IKKalpha/beta control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator RIPK1.
    Hepatology. 2016 Jul 11. doi: 10.1002/hep.28723.
    PubMed     Text format     Abstract available


  611. LANGBERG KM, Taddei TH
    Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28717.
    PubMed     Text format    


  612. VERGANI D, Mieli-Vergani G
    Mouse model of primary biliary cholangitis with a striking female predominance: A new powerful research tool.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28718.
    PubMed     Text format    


  613. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1-3.
    PubMed     Text format    


    June 2016
  614. CUERVO H, Nielsen CM, Simonetto DA, Ferrell L, et al
    Endothelial Notch signaling is essential to prevent hepatic vascular malformations in mice.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28713.
    PubMed     Text format     Abstract available


  615. CALDERARO J, Rousseau B, Amaddeo G, Mercey M, et al
    PD-L1 expression in hepatocellular carcinoma: Relationship with clinical and pathological features.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28710.
    PubMed     Text format     Abstract available


  616. WU D, Liu G, Liu Y, Saiyin H, et al
    Zinc finger protein 191 inhibits hepatocellular carcinoma metastasis via discs large 1-mediated yes associated protein inactivation.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28708.
    PubMed     Text format     Abstract available


  617. ARAB JP, Karpen SJ, Dawson PA, Arrese M, et al
    Bile acids & nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28709.
    PubMed     Text format     Abstract available


  618. DONEPUDI AC, Boehme S, Li F, Chiang JY, et al
    G protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis.
    Hepatology. 2016 Jun 28. doi: 10.1002/hep.28707.
    PubMed     Text format     Abstract available


  619. KALAMBOKIS GN, Oikonomou A, Christou L, Baltayiannis G, et al
    High von Willebrand factor antigen levels and procoagulant imbalance may be involved in both increasing severity of cirrhosis and portal vein thrombosis.
    Hepatology. 2016 Jun 27. doi: 10.1002/hep.28703.
    PubMed     Text format    


  620. GANNE-CARRIE N, Layese R, Bourcier V, Cagnot C, et al
    Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir).
    Hepatology. 2016 Jun 27. doi: 10.1002/hep.28702.
    PubMed     Text format     Abstract available


  621. HANNAH WN JR, Harrison SA
    Non-invasive Imaging Methods to Determine Severity of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Hepatology. 2016 Jun 24. doi: 10.1002/hep.28699.
    PubMed     Text format     Abstract available


  622. KANG DJ, Betrapally NS, Ghosh SA, Sartor RB, et al
    Gut microbiota drive the development of neuro-inflammatory response in cirrhosis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28696.
    PubMed     Text format     Abstract available


  623. SUK KT, Yoon JH, Kim MY, Kim CW, et al
    Transplantation with Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 Trial.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28693.
    PubMed     Text format     Abstract available


  624. ZHANG H, Xing Z, Mani SK, Bancel B, et al
    RNA helicase DDX5 regulates PRC2/HOTAIR function in Hepatitis B Virus infection and hepatocarcinogenesis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28698.
    PubMed     Text format     Abstract available


  625. SPENGLER EK, Kleiner DE, Fontana RJ
    Vemurafenib-induced Granulomatous hepatitis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28692.
    PubMed     Text format    


  626. CUI J, Chen CH, Lo MT, Schork N, et al
    Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.
    Hepatology. 2016 Jun 17. doi: 10.1002/hep.28674.
    PubMed     Text format     Abstract available


  627. DI PASCOLI M, Zampieri F, Verardo A, Pesce P, et al
    Inhibition of EETs production in cirrhotic rats has beneficial effects on portal hypertension by reducing splanchnic vasodilation.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28686.
    PubMed     Text format     Abstract available


  628. THOMSEN MK, Nandakumar R, Stadler D, Malo A, et al
    Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28685.
    PubMed     Text format     Abstract available


  629. PLOEGER C, Waldburger N, Fraas A, Goeppert B, et al
    Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28684.
    PubMed     Text format     Abstract available


  630. SETIAWAN VW, Stram DO, Porcel J, Lu SC, et al
    Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The Multiethnic Cohort.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28677.
    PubMed     Text format     Abstract available


  631. FENG S, Demetris AJ, Spain KM, Kanaparthi S, et al
    Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28681.
    PubMed     Text format     Abstract available


  632. MARQUARDT JU
    Deconvolution of the cellular origin in hepatocellular carcinoma - hepatocytes take the center stage.
    Hepatology. 2016 Jun 10. doi: 10.1002/hep.28671.
    PubMed     Text format    


  633. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1749-1751.
    PubMed     Text format    


    May 2016
  634. INZAUGARAT ME, Wree A, Feldstein AE
    Hepatocyte mitochondrial DNA released in microparticles and TLR9 activation: A link between lipotoxicity and inflammation during NASH.
    Hepatology. 2016 May 30. doi: 10.1002/hep.28666.
    PubMed     Text format    


  635. CHIU DK, Xu IM, Lai RK, Tse AP, et al
    Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28655.
    PubMed     Text format     Abstract available


  636. SUNG FY, Lan CY, Huang CJ, Lin CL, et al
    Progressive accumulation of mutations in the hepatitis B virus genome and its impact for time to diagnosis of hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28654.
    PubMed     Text format     Abstract available


  637. ZEISEL MB, Baumert TF
    Translation and protein expression of lncRNAs: Impact for liver disease and hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28653.
    PubMed     Text format    


  638. IWAKIRI Y
    The Lymphatic system: A new frontier in hepatology.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28650.
    PubMed     Text format    


  639. MATSUURA K, De Giorgi V, Schechterly C, Wang RY, et al
    Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28660.
    PubMed     Text format     Abstract available


  640. LEE SA, Yuen JJ, Jiang H, Kahn BB, et al
    Adipocyte-specific over-expression of retinol-binding protein 4 (RBP4) causes hepatic steatosis in mice.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28659.
    PubMed     Text format     Abstract available


  641. ZOU Y, Li G, Wang L
    Colony-stimulating factor 1 should be considered when studying the miR-28-5p-IL-34-macrophage feedback loop in hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28658.
    PubMed     Text format    


  642. HAPPERTS S, Foucault A, Billiard JS, Nguyen B, et al
    Combined hepatocellular-cholangiocarcinoma in a patient with Abernethy malformation and Tetralogy of Fallot - A case report.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28656.
    PubMed     Text format    


  643. PIANO S, Angeli P
    Terlipressin administration for type 1 hepatorenal syndrome. More answers than open questions.
    Hepatology. 2016 May 17. doi: 10.1002/hep.28648.
    PubMed     Text format    


  644. HEWETT LJ, Bradshaw ML, Gordon LL, Rockey DC, et al
    Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28634.
    PubMed     Text format    


  645. SAPISOCHIN G, Goldaracena N, Laurence JM, Dib M, et al
    The extended toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28643.
    PubMed     Text format     Abstract available


  646. WAN ZY, Tian JS, Tan HW, Chow AL, et al
    Mechanistic target of rapamycin complex 1 (mTORC1) is an essential mediator of metabolic and mitogenic effects of FGF19 in hepatoma cells.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28639.
    PubMed     Text format     Abstract available


  647. LI D, Fu J, Du M, Zhang H, et al
    Hepatocellular carcinoma repression by TNFalpha-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28637.
    PubMed     Text format     Abstract available


  648. LIU M, Chen L, Ma NF, Chow RK, et al
    CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.
    Hepatology. 2016;63:1544-1559.
    PubMed     Text format     Abstract available


  649. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1405-1407.
    PubMed     Text format    


  650. VALANEJAD L, Timchenko N
    Akt-FoxO1 axis controls liver regeneration.
    Hepatology. 2016;63:1424-6.
    PubMed     Text format    


  651. BEZERRA JA
    MDR3 mutation analysis: A step closer to precision medicine.
    Hepatology. 2016;63:1421-3.
    PubMed     Text format    


  652. BLOKS VW, Plosch T, Jonker JW, Kuipers F, et al
    Reply to: "Impaired expression of multidrug resistance-associated protein 2 and liver damage in erythropoietic protoporphyria".
    Hepatology. 2016;63:1743-4.
    PubMed     Text format    


  653. SCHWIMMER JB
    Clinical advances in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2016;63:1718-25.
    PubMed     Text format    


  654. LIASKOU E, Klemsdal Henriksen EK, Holm K, Kaveh F, et al
    High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.
    Hepatology. 2016;63:1608-19.
    PubMed     Text format     Abstract available


    April 2016
  655. DROLZ A, Horvatits T, Roedl K, Rutter K, et al
    Coagulation parameters and major bleeding in critically ill patients with cirrhosis.
    Hepatology. 2016 Apr 28. doi: 10.1002/hep.28628.
    PubMed     Text format     Abstract available


  656. HSIN IF, Montano E, Seki E
    Finding a new role for NEMO: A key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1.
    Hepatology. 2016 Apr 27. doi: 10.1002/hep.28627.
    PubMed     Text format    


  657. TANG H, Bai HX, Su C, Lee AM, et al
    The effect of cirrhosis on radiogenomic biomarker's ability to predict microvascular invasion and outcome in hepatocellular carcinoma.
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28620.
    PubMed     Text format    


  658. MALIZIA G, Cervello OV, D'Amico G
    Statins in cirrhosis: The magic pill?
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28616.
    PubMed     Text format    


  659. WU N, Meng F, Invernizzi P, Bernuzzi F, et al
    The secretin/secretin receptor axis modulates liver fibrosis through changes in TGF-beta1 biliary secretion.
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28622.
    PubMed     Text format     Abstract available


  660. SHIN S, Wangensteen KJ, Teta-Bissett M, Wang YJ, et al
    Genetic Lineage Tracing Analysis of the Cell of Origin of Hepatotoxin-Induced Liver Tumors in Mice.
    Hepatology. 2016 Apr 21. doi: 10.1002/hep.28602.
    PubMed     Text format     Abstract available


  661. CHENG AL, Thongprasert S, Lim HY, Sukeepaisarnjaroen W, et al
    Randomized, Open-Label Phase 2 Study Comparing Frontline Dovitinib vs Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
    Hepatology. 2016 Apr 15. doi: 10.1002/hep.28600.
    PubMed     Text format     Abstract available


  662. GLUUD LL, Vilstrup H, Morgan MY
    Non-Absorbable Disaccharides for Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.
    Hepatology. 2016 Apr 15. doi: 10.1002/hep.28598.
    PubMed     Text format     Abstract available


  663. ARRIVE L, Zucman-Rossi J, Balladur P, Wendum D, et al
    Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis.
    Hepatology. 2016 Apr 4. doi: 10.1002/hep.28590.
    PubMed     Text format    



  664. Correction: Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Hepatology. 2016;63:1403.
    PubMed     Text format    


  665. CUBERO FJ
    Shutting off inflammation: A novel switch on hepatic stellate cells.
    Hepatology. 2016;63:1086-9.
    PubMed     Text format    


  666. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1065-7.
    PubMed     Text format    


  667. MOLLER S
    Toward new standards for noninvasive measuring of portal pressure?
    Hepatology. 2016;63:1384-6.
    PubMed     Text format    


  668. VINCIGUERRA M, Mazzoccoli G
    Aryl hydrocarbon receptor-fibroblast growth factor 21 dissociation of fatty liver from insulin resistance: A timely matter?
    Hepatology. 2016;63:1396-7.
    PubMed     Text format    


  669. LU P, Xie W
    Reply.
    Hepatology. 2016;63:1397-8.
    PubMed     Text format    


  670. STEFANESCU H, Lupsor-Platon M, Badea RI
    The devil's triangle of steatosis, obesity, and liver stiffness.
    Hepatology. 2016;63:1392-3.
    PubMed     Text format    


  671. PETTA S, Craxi A
    Reply.
    Hepatology. 2016;63:1394.
    PubMed     Text format    


  672. TAPPER EB, Lai M
    Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort study.
    Hepatology. 2016;63:1184-9.
    PubMed     Text format     Abstract available


  673. UNALP-ARIDA A, Ruhl CE
    Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Hepatology. 2016;63:1170-83.
    PubMed     Text format     Abstract available


  674. GUAL P, Postic C
    Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease.
    Hepatology. 2016;63:1074-7.
    PubMed     Text format    


  675. THORGEIRSSON SS
    Stemness and reprogramming in liver cancer.
    Hepatology. 2016;63:1068-70.
    PubMed     Text format    


  676. GARIANI K, Menzies KJ, Ryu D, Wegner CJ, et al
    Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
    Hepatology. 2016;63:1190-204.
    PubMed     Text format     Abstract available


  677. SHNEIDER BL, de Ville de Goyet J, Leung DH, Srivastava A, et al
    Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium.
    Hepatology. 2016;63:1368-80.
    PubMed     Text format     Abstract available


  678. PIANO S, Fasolato S, Salinas F, Romano A, et al
    The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.
    Hepatology. 2016;63:1299-309.
    PubMed     Text format     Abstract available


    March 2016
  679. SERLIE MJ, Ter Horst KW, Brown AW
    Addendum: Hypercaloric diets with high meal frequency, but not increased meal size, increase intrahepatic triglycerides: A randomized controlled trial.
    Hepatology. 2016 Mar 31. doi: 10.1002/hep.28588.
    PubMed     Text format    


  680. KAI AK, Chan LK, Lo RC, Lee JM, et al
    Downregulation of TIMP2 via HIF-1alpha/miR-210/HIF-3alpha regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.
    Hepatology. 2016 Mar 28. doi: 10.1002/hep.28577.
    PubMed     Text format     Abstract available


  681. KALAMBOKIS GN, Christodoulou D, Baltayiannis G, Christou L, et al
    Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites.
    Hepatology. 2016 Mar 26. doi: 10.1002/hep.28575.
    PubMed     Text format    


  682. ARAB JP, Shah VH
    Statins and portal hypertension: A tale of two models.
    Hepatology. 2016 Mar 25. doi: 10.1002/hep.28567.
    PubMed     Text format    


  683. REZVANI M, Grimm A, Willenbring H
    Assessing the Therapeutic Potential of Lab-Made Hepatocytes.
    Hepatology. 2016 Mar 25. doi: 10.1002/hep.28569.
    PubMed     Text format     Abstract available


  684. MARRONE J, Soria LR, Danielli M, Lehmann GL, et al
    Hepatic Gene Transfer of Human Aquaporin-1 Improves Bile Salt Secretory Failure in Rats with Estrogen-Induced Cholestasis.
    Hepatology. 2016 Mar 21. doi: 10.1002/hep.28564.
    PubMed     Text format     Abstract available


  685. KANWAL F, Asch SM, Kramer JR, Cao Y, et al
    Early Outpatient Follow-up and 30-day Outcomes in Patients Hospitalized with Cirrhosis.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28558.
    PubMed     Text format     Abstract available


  686. RAO Q, Zuo B, Lu Z, Gao X, et al
    Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and human in vitro.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28549.
    PubMed     Text format     Abstract available


  687. TAKASHIMA Y, Terada M, Udono M, Miura S, et al
    Suppression of let-7b and miR-125a/b maturation by Lin28b enables maintenance of stem cell properties in hepatoblasts.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28548.
    PubMed     Text format     Abstract available


  688. BISSONNETTE J, Garcia-Pagan JC, Albillos A, Turon F, et al
    Role of the Transjugular Intrahepatic Portosystemic Shunt in the Management of Severe Complications of Portal Hypertension in Idiopathic Noncirrhotic Portal Hypertension.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28547.
    PubMed     Text format     Abstract available


  689. TREVISANI F, Golfieri R
    Lipiodol transarterial chemoembolization for hepatocellular carcinoma: Where are we now?
    Hepatology. 2016 Mar 16. doi: 10.1002/hep.28554.
    PubMed     Text format    


  690. ALVARO D, Gaudio E
    Biliary tree stem cell subpopulations.
    Hepatology. 2016 Mar 12. doi: 10.1002/hep.28546.
    PubMed     Text format    


  691. MCPHAIL MJ, Auzinger G, Bernal W, Wendon JA, et al
    Decisions on futility in patients with cirrhosis and organ failure.
    Hepatology. 2016 Mar 7. doi: 10.1002/hep.28539.
    PubMed     Text format    


  692. GUSTOT T, Fernandez J, Pavesi M, Arroyo V, et al
    Reply to "Decisions on futility in patients with cirrhosis and organ failure".
    Hepatology. 2016 Mar 7. doi: 10.1002/hep.28538.
    PubMed     Text format    


  693. ABRALDES JG, Burak KW
    STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28537.
    PubMed     Text format    


  694. EL-SERAG HB, Kanwal F, Richardson P, Kramer J, et al
    Risk of Hepatocellular Carcinoma after Sustained Virologic Response in Veterans with HCV-infection.
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28535.
    PubMed     Text format     Abstract available



  695. Correction: Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
    Hepatology. 2016;63:1064.
    PubMed     Text format    



  696. Correction: Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition via Akt/GSK-3beta/snail signaling.
    Hepatology. 2016;63:1064.
    PubMed     Text format    


  697. SAMARIN J, Laketa V, Malz M, Roessler S, et al
    PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
    Hepatology. 2016;63:813-26.
    PubMed     Text format     Abstract available


  698. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:679-81.
    PubMed     Text format    


  699. GUY CD, Diehl AM
    Reply.
    Hepatology. 2016;63:1057-8.
    PubMed     Text format    


  700. ROMAGNOLI R, Mazzaferro V, Bruix J
    Reply.
    Hepatology. 2016;63:1054-5.
    PubMed     Text format    


  701. BOHM M, Vuppalanchi R, Chalasani N
    Febuxostat-induced acute liver injury.
    Hepatology. 2016;63:1047-9.
    PubMed     Text format    


  702. MANN JP, De Vito R, Mosca A, Alisi A, et al
    Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2016;63:745-53.
    PubMed     Text format     Abstract available


  703. LEE YH, Kim SU, Song K, Park JY, et al
    Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Hepatology. 2016;63:776-86.
    PubMed     Text format     Abstract available


  704. DIBRA D, Xia X, Mitra A, Cutrera JJ, et al
    Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice.
    Hepatology. 2016;63:1000-12.
    PubMed     Text format     Abstract available


  705. DONATI B, Motta BM, Pingitore P, Meroni M, et al
    The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Hepatology. 2016;63:787-98.
    PubMed     Text format     Abstract available


  706. BOURSIER J, Mueller O, Barret M, Machado M, et al
    The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Hepatology. 2016;63:764-75.
    PubMed     Text format     Abstract available


  707. BJORNSSON ES, Olafsson JH
    Concomitant drug-induced liver and skin reactions: An Indian experience.
    Hepatology. 2016;63:700-2.
    PubMed     Text format    


  708. SENIOR JR
    Can rechallenge be done safely after mild or moderate drug-induced liver injury?
    Hepatology. 2016;63:691-3.
    PubMed     Text format    


  709. MEHAL WZ
    We are not in Kansas anymore: The unfamiliar landscape of NASH.
    Hepatology. 2016;63:682-4.
    PubMed     Text format    


  710. RINELLA ME
    Screening for nonalcoholic fatty liver disease in patients with atherosclerotic coronary disease?--In principle yes, in practice not yet.
    Hepatology. 2016;63:688-90.
    PubMed     Text format    


  711. DEVARBHAVI H, Raj S, Aradya VH, Rangegowda VT, et al
    Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
    Hepatology. 2016;63:993-9.
    PubMed     Text format     Abstract available


  712. WONG VW, Wong GL, Yeung JC, Fung CY, et al
    Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study.
    Hepatology. 2016;63:754-63.
    PubMed     Text format     Abstract available


  713. BERZIGOTTI A, Saran U, Dufour JF
    Physical activity and liver diseases.
    Hepatology. 2016;63:1026-40.
    PubMed     Text format     Abstract available


    February 2016
  714. YAO L, Wang C, Zhang X, Peng L, et al
    Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor-CD36 Pathway to Promote Hepatic Steatosis in Mice.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28518.
    PubMed     Text format     Abstract available


  715. CHEN YY, Jeffery HC, Hunter S, Bhogal R, et al
    Human intrahepatic tregs are functional, require IL-2 from effector cells for survival and are susceptible to fas ligand mediated apoptosis.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28517.
    PubMed     Text format     Abstract available


  716. LEE TH, Rangan V, Khallafi H
    A Case of Sphenoid Sinus Metastasis in Hepatocellular Carcinoma.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28516.
    PubMed     Text format    


  717. GONG Q, Hu Z, Zhang F, Cui A, et al
    Fibroblast Growth Factor 21 Improves Hepatic Insulin Sensitivity by Inhibiting Mammalian Target of Rapamycin Complex 1.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28523.
    PubMed     Text format     Abstract available


  718. DE WAART DR, Naik J, Utsunomiya KS, Duijst S, et al
    ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28522.
    PubMed     Text format     Abstract available


  719. TANIMIZU N, Kaneko K, Itoh T, Ichinohe N, et al
    Intrahepatic bile ducts are developed through formation of homogeneous continuous luminal network and its dynamic rearrangement.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28521.
    PubMed     Text format     Abstract available


  720. LIU C, Liu L, Chen X, Cheng J, et al
    Sox9 Regulates Self-Renewal and Tumorigenicity by Promoting Symmetrical Cell Division of Cancer Stem Cells in Hepatocellular Carcinoma.
    Hepatology. 2016 Feb 22. doi: 10.1002/hep.28509.
    PubMed     Text format     Abstract available


  721. LI L, Che L, Tharp KM, Park HM, et al
    Differential Requirement for de novo Lipogenesis in Cholangiocarcinoma and Hepatocellular Carcinoma of Mice and Humans.
    Hepatology. 2016 Feb 22. doi: 10.1002/hep.28508.
    PubMed     Text format     Abstract available


  722. SIMON TG, Bonilla H, Yan P, Chung RT, et al
    Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and HCC, among patients with HCV Results from ERCHIVES.
    Hepatology. 2016 Feb 18. doi: 10.1002/hep.28506.
    PubMed     Text format     Abstract available


  723. D'AMICO G, Malizia G, Bosch J
    Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?
    Hepatology. 2016 Feb 18. doi: 10.1002/hep.28502.
    PubMed     Text format    


  724. VILARINHO S, Sari S, Yilmaz G, Stiegler AL, et al
    Recurrent Recessive Mutation in DGUOK Causes Idiopathic Non-Cirrhotic Portal Hypertension.
    Hepatology. 2016 Feb 13. doi: 10.1002/hep.28499.
    PubMed     Text format     Abstract available


  725. CRAIG A, Villanueva A
    Liver Capsule: Molecular-based signatures in hepatocellular carcinoma.
    Hepatology. 2016 Feb 9. doi: 10.1002/hep.28489.
    PubMed     Text format    


  726. WU W, Patel A, Kyostila K, Lohi H, et al
    Genome-wide Association Study in Mice Identifies Loci Affecting Liver-related Phenotypes Including Sel1l Influencing Serum Bile Acids.
    Hepatology. 2016 Feb 9. doi: 10.1002/hep.28495.
    PubMed     Text format     Abstract available


  727. VILAR-GOMEZ E, Yasells-Garcia A, Martinez-Perez Y, Calzadilla-Bertot L, et al
    Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.
    Hepatology. 2016 Feb 5. doi: 10.1002/hep.28484.
    PubMed     Text format     Abstract available


  728. OIKAWA T
    Cancer Stem Cells and Their Cellular Origins in Primary Liver and Biliary Tract Cancers.
    Hepatology. 2016 Feb 5. doi: 10.1002/hep.28485.
    PubMed     Text format     Abstract available


  729. TREBICKA J, Schierwagen R
    Hepatic mitochondrial dysfunction in non-alcoholic steatohepatitis: Read-out or reason?
    Hepatology. 2016 Feb 4. doi: 10.1002/hep.28482.
    PubMed     Text format    


  730. TAI WT, Chen YL, Chu PY, Chen LJ, et al
    Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.
    Hepatology. 2016 Feb 3. doi: 10.1002/hep.28478.
    PubMed     Text format     Abstract available


  731. SAMI S, Mariella C, Valeria DC, Daniele A, et al
    A low-cost, user-friendly EEG recording system for the assessment of hepatic encephalopathy.
    Hepatology. 2016 Feb 2. doi: 10.1002/hep.28477.
    PubMed     Text format     Abstract available


  732. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:351-3.
    PubMed     Text format    


  733. PANG Q, Qu K, Liu C, Zhang JY, et al
    Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link.
    Hepatology. 2016;63:675.
    PubMed     Text format    


  734. HONG HC, Choi KM
    Reply.
    Hepatology. 2016;63:675-6.
    PubMed     Text format    


  735. SMAGRIS E, BasuRay S, Gromada J, Cohen JC, et al
    Reply.
    Hepatology. 2016;63:677.
    PubMed     Text format    


  736. ZHAO J, Lawless MW
    Resminostat: Opening the door to epigenetic treatments for liver cancer.
    Hepatology. 2016;63:668-9.
    PubMed     Text format    


  737. CUI J, Heba E, Hernandez C, Haufe W, et al
    Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
    Hepatology. 2016;63:453-61.
    PubMed     Text format     Abstract available


  738. HOLSTER IL, Tjwa ET, Moelker A, Wils A, et al
    Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding.
    Hepatology. 2016;63:581-9.
    PubMed     Text format     Abstract available


  739. BJORNSSON ES, Hoofnagle JH
    Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.
    Hepatology. 2016;63:590-603.
    PubMed     Text format     Abstract available


  740. REID LM, Sethupathy P
    The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
    Hepatology. 2016;63:662-4.
    PubMed     Text format    


    January 2016
  741. TAPPER EB
    Challenge accepted: Confronting readmissions for our patients with cirrhosis.
    Hepatology. 2016 Jan 25. doi: 10.1002/hep.28471.
    PubMed     Text format    


  742. SACK J, Garcia-Tsao G
    Variceal hemorrhage in a patient with HCV cirrhosis in whom liver synthetic function had normalized after viral elimination.
    Hepatology. 2016 Jan 25. doi: 10.1002/hep.28470.
    PubMed     Text format    


  743. KOH MY, Gagea M, Sargis T, Lemos R Jr, et al
    A new HIF-1alpha/RANTES driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28468.
    PubMed     Text format     Abstract available


  744. KWO P, Gitlin N, Nahass R, Bernstein D, et al
    Simeprevir Plus Sofosbuvir (12 and 8 Weeks) in HCV Genotype 1-Infected Patients Without Cirrhosis: OPTIMIST-1, a Phase 3, Randomized Study.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28467.
    PubMed     Text format     Abstract available


  745. NORONHA FERREIRA C, Seijo S, Plessier A, Silva-Junior G, et al
    Natural history and management of esophagogastric varices in chronic non-cirrhotic non-tumoral portal vein thrombosis.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28466.
    PubMed     Text format     Abstract available


  746. CALVISI DF
    Accomplices in Crime: The Diabolical Liaison between PTP1B and Ras in Hepatocellular Carcinoma.
    Hepatology. 2016 Jan 19. doi: 10.1002/hep.28462.
    PubMed     Text format    


  747. LENCIONI R, de Baere T, Soulen MC, Rilling WS, et al
    Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.
    Hepatology. 2016 Jan 13. doi: 10.1002/hep.28453.
    PubMed     Text format     Abstract available


  748. TADDEI T
    Learning from the Melbourne experience: How reliable are cancer registry data for hepatocellular carcinoma?
    Hepatology. 2016 Jan 13. doi: 10.1002/hep.28452.
    PubMed     Text format    


  749. DESAI SS, Tung JC, Zhou VX, Grenert JP, et al
    Physiological Ranges of Matrix Rigidity Modulate Primary Mouse Hepatocyte Function In Part Through Hepatocyte Nuclear Factor 4 Alpha.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28450.
    PubMed     Text format     Abstract available


  750. POORDAD F, Schiff ER, Vierling JM, Landis C, et al
    Daclatasvir With Sofosbuvir and Ribavirin for HCV Infection With Advanced Cirrhosis or Post-Liver Transplant Recurrence.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28446.
    PubMed     Text format     Abstract available


  751. ZHOU SL, Hu ZQ, Zhou ZJ, Dai Z, et al
    miR-28-5p-IL-34-Macrophage Feedback Loop Modulates Hepatocellular Carcinoma Metastasis.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28445.
    PubMed     Text format     Abstract available


  752. ZHAO L, Wong LL, Shi X, Ji J, et al
    Should hepatic dysplasia nodules and regenerative nodules be regarded as pre-malignant lesions and treated?
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28444.
    PubMed     Text format    


  753. SUNAMI Y, Ringelhan M, Kokai E, Lu M, et al
    Canonical NF-kappaB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28435.
    PubMed     Text format     Abstract available



  754. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis.
    Hepatology. 2016;63:349.
    PubMed     Text format    



  755. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition.
    Hepatology. 2016;63:349.
    PubMed     Text format    


  756. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1-3.
    PubMed     Text format    


  757. LIM KC, Chow PK
    Reply.
    Hepatology. 2016;63:345.
    PubMed     Text format    


  758. DONG C, Peng S
    Contribution of nonignorable environmental factor to impairing liver disease mortality reduction target in China.
    Hepatology. 2016;63:347-8.
    PubMed     Text format    


  759. ZHANG Z, Gao B, Wang FS
    Reply.
    Hepatology. 2016;63:348.
    PubMed     Text format    


  760. GIANNINI EG, Stravitz RT, Caldwell SH
    Portal vein thrombosis and chronic liver disease progression: The closer you look the more you see.
    Hepatology. 2016;63:342-3.
    PubMed     Text format    


  761. DE MATTOS AZ, de Mattos AA
    Model for end-stage liver disease-based allocation system: On the right path, but not there yet.
    Hepatology. 2016;63:344.
    PubMed     Text format    


  762. ROSSO C, Mezzabotta L, Gaggini M, Salomone F, et al
    Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease.
    Hepatology. 2016;63:107-16.
    PubMed     Text format     Abstract available


  763. GOFFREDO M, Caprio S, Feldstein AE, D'Adamo E, et al
    Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.
    Hepatology. 2016;63:117-25.
    PubMed     Text format     Abstract available


  764. DUFOUR JF
    Time to Abandon NASH?
    Hepatology. 2016;63:9-10.
    PubMed     Text format    


  765. KOEHLER EM, Plompen EP, Schouten JN, Hansen BE, et al
    Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.
    Hepatology. 2016;63:138-47.
    PubMed     Text format     Abstract available


    December 2015
  766. WANG PX, Zhang XJ, Li H
    IRFs in hepatocytes pathophysiology.
    Hepatology. 2015 Dec 28. doi: 10.1002/hep.28433.
    PubMed     Text format    


  767. OH Y, Park O, Swierczewska M, Hamilton JP, et al
    Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
    Hepatology. 2015 Dec 28. doi: 10.1002/hep.28432.
    PubMed     Text format     Abstract available


  768. INTAGLIATA NM, Caldwell SH, Porte RJ, Lisman T, et al
    Prediction of bleeding in cirrhosis patients: Is the forecast any clearer?
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28426.
    PubMed     Text format    


  769. LAWITZ E, Matusow G, DeJesus E, Yoshida EM, et al
    Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A Phase 3 study (OPTIMIST-2).
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28422.
    PubMed     Text format     Abstract available


  770. TANOUE S, Kaplan DE
    CD14 regulatory Dendritic Cells in Hepatocellular Carcinoma and Cirrhotic patients.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28419.
    PubMed     Text format    


  771. MAZZAFERRO V
    Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28420.
    PubMed     Text format    


  772. XIAO S, Chang RM, Yang MY, Lei X, et al
    ACTL6A predicts poor prognosis of Hepatocellular carcinoma and promotes metastasis and Epithelial-mesenchymal transition.
    Hepatology. 2015 Dec 23. doi: 10.1002/hep.28417.
    PubMed     Text format     Abstract available


  773. WANG MD, Wu H, Fu GB, Zhang HL, et al
    Acetyl-CoA carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.
    Hepatology. 2015 Dec 23. doi: 10.1002/hep.28415.
    PubMed     Text format     Abstract available


  774. BAJAJ JS, Reddy KR, Tandon P, Wong F, et al
    The Three-Month Readmission Rate Remains Unacceptably High in a Large North American Cohort of Cirrhotic Patients.
    Hepatology. 2015 Dec 21. doi: 10.1002/hep.28414.
    PubMed     Text format     Abstract available


  775. IWAGAMI Y, Huang CK, Olsen MJ, Thomas JM, et al
    Aspartate beta-hydroxylase modulates cellular senescence via glycogen synthase kinase 3beta in hepatocellular carcinoma.
    Hepatology. 2015 Dec 19. doi: 10.1002/hep.28411.
    PubMed     Text format     Abstract available


  776. FURUTA K, Yoshida Y, Ogura S, Kurahashi T, et al
    Gab1 adaptor protein acts as a gatekeeper to balance hepatocyte death and proliferation during acetaminophen-induced liver injury in mice.
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28410.
    PubMed     Text format     Abstract available


  777. GUO Y, Wang J, Zhang L, Shen S, et al
    Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28409.
    PubMed     Text format     Abstract available


  778. MEHTA N, Yao FY
    Nucleos(t)ide analogues to reduce the risk of Hepatitis B associated hepatocellular carcinoma: A can't miss proposition?
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28404.
    PubMed     Text format    


  779. ZHOU CC, Yang F, Yuan SX, Ma JZ, et al
    Systemic genome screening identified the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28393.
    PubMed     Text format     Abstract available


  780. OUYANG HY, Xu J, Luo J, Zou RH, et al
    MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28397.
    PubMed     Text format     Abstract available


  781. CAVALLIN M, Piano S, Romano A, Fasolato S, et al
    Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28396.
    PubMed     Text format     Abstract available


  782. ZHANG Y, Liu Y, Duan J, Yan H, et al
    Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21 stabilization via activating ERK1/2-MAPK pathway.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28395.
    PubMed     Text format     Abstract available


  783. LAN X, Yan J, Ren J, Zhong B, et al
    A Novel Long Non-coding RNA Lnc-HC Binds hnRNPA2B1 to Regulate Expressions of Cyp7a1 and Abca1 in Hepatocytic Cholesterol Metabolism.
    Hepatology. 2015 Dec 11. doi: 10.1002/hep.28391.
    PubMed     Text format     Abstract available


  784. TOSELLO-TRAMPONT AC, Krueger P, Narayanan S, Landes SG, et al
    NKp46 NK cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation.
    Hepatology. 2015 Dec 10. doi: 10.1002/hep.28389.
    PubMed     Text format     Abstract available


  785. CHEN DS, Liaw YF, Chen CJ, Wu JC, et al
    Differences in hepatitis viral etiology of hepatocellular carcinoma in Taiwan and China.
    Hepatology. 2015 Dec 10. doi: 10.1002/hep.28378.
    PubMed     Text format    


  786. LOCATELLI L, Cadamuro M, Spirli C, Fiorotto R, et al
    Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis.
    Hepatology. 2015 Dec 8. doi: 10.1002/hep.28382.
    PubMed     Text format     Abstract available


  787. SEKI E
    HEDGEHOG signal in Hepatocytes mediates Macrophage Recruitment: A New Mechanism and Potential Therapeutic Target for Fatty Liver Disease.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28381.
    PubMed     Text format    


  788. CHO NE, Bang BR, Gurung P, Li M, et al
    Retinoid Regulation of Antiviral Innate Immunity in Hepatocytes.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28380.
    PubMed     Text format     Abstract available


  789. EKSTEEN B
    Predicting risk in Primary Biliary Cholangitis.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28377.
    PubMed     Text format    



  790. 2015 Hepatology referees (volumes 61 and 62).
    Hepatology. 2015;62:1926-1930.
    PubMed     Text format    


  791. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:1649-1651.
    PubMed     Text format    


    November 2015
  792. GUO H, Jing L, Cheng Y, Atsaves V, et al
    Downregulation of the Cyclin-Dependent Kinase Inhibitor p57 Is Mediated by Jab1/Csn5 in Hepatocarcinogenesis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28372.
    PubMed     Text format     Abstract available


  793. BLASI A, Hernandez-Gea V, Reverter JC, Garcia-Pagan JC, et al
    Quality of anticoagulation and outcome of bleeding in cirrhosis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28371.
    PubMed     Text format    


  794. QI X, De Stefano V, Guo X
    Quality of anticoagulation and outcome of bleeding in cirrhosis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28369.
    PubMed     Text format    


  795. BOSSEN L, Krag A, Vilstrup H, Watson H, et al
    Non-selective beta-blockers do not affect mortality in cirrhosis patients with ascites: Post hoc analysis of three RCTs with 1198 patients.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28352.
    PubMed     Text format     Abstract available


  796. PISCAGLIA F, Svegliati-Baroni G, Barchetti A, Pecorelli A, et al
    Clinical patterns of hepatocellular carcinoma (hcc) in non alcoholic fatty liver disease (NAFLD): A multicenter prospective study.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28368.
    PubMed     Text format     Abstract available


  797. JUNG KH, Zhang J, Zhou C, Shen H, et al
    Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28367.
    PubMed     Text format     Abstract available


  798. REYES H
    Sulfated progesterone metabolites in the pathogenesis of intrahepatic cholestasis of pregnancy: Another loop in the ascending spiral of medical knowledge.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28365.
    PubMed     Text format    


  799. FERRER-FABREGA J, Forner A, Liccioni A, Miquel R, et al
    Prospective validation of "ab initio" liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28339.
    PubMed     Text format     Abstract available


  800. GALUN E
    Liver inflammation and cancer: The role of tissue microenvironment in generating the tumor-promoting niche (TPN) in the development of hepatocellular carcinoma.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28344.
    PubMed     Text format    


  801. DOSHI M, Pereira K, Carrion A, Martin P, et al
    Antegrade embolization of spontaneous splenorenal shunt for Post-TIPS refractory Hepatic Encephalopathy.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28343.
    PubMed     Text format    


  802. FERNANDEZ J, Tandon P, Mensa J, Garcia-Tsao G, et al
    Antibiotic prophylaxis in cirrhosis: Good and bad.
    Hepatology. 2015 Nov 3. doi: 10.1002/hep.28330.
    PubMed     Text format     Abstract available


  803. JAESCHKE H, Du K
    Benzyl Alcohol: A novel treatment for acetaminophen overdose?
    Hepatology. 2015;62:1641-2.
    PubMed     Text format    


  804. ZUCKERBRAUN BS, Cai C, Billiar TR
    Reply: To PMID 24798499.
    Hepatology. 2015;62:1642.
    PubMed     Text format    


  805. YANG T, Zhang H, Lau WY, Shen F, et al
    Liver disease in China: A long way to go.
    Hepatology. 2015;62:1640.
    PubMed     Text format    


  806. ZHANG Z, Fan JG, Wang FS
    Reply: To PMID 25164003.
    Hepatology. 2015;62:1640-1.
    PubMed     Text format    


  807. BLECHACZ B, Mishra L
    Biopsy for liver cancer: How to balance research needs with evidence-based clinical practice.
    Hepatology. 2015;62:1645.
    PubMed     Text format    


  808. LEUNG DH, Khan M, Minard CG, Guffey D, et al
    Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Hepatology. 2015;62:1576-83.
    PubMed     Text format     Abstract available


  809. SIDDIQUE HR, Feldman DE, Chen CL, Punj V, et al
    NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.
    Hepatology. 2015;62:1466-79.
    PubMed     Text format     Abstract available


  810. JO YS, Ryu D, Maida A, Wang X, et al
    Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice.
    Hepatology. 2015;62:1606-18.
    PubMed     Text format     Abstract available


  811. HAGIWARA S, Nishida N, Park AM, Sakurai T, et al
    Impaired expression of ATP-binding cassette transporter G2 and liver damage in erythropoietic protoporphyria.
    Hepatology. 2015;62:1638-9.
    PubMed     Text format    


    October 2015
  812. YOKOMORI H, Yamazaki H, Oda M
    Freshwater clam extract supplement induced acute cholestasis.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28320.
    PubMed     Text format    


  813. STINDT J, Kluge S, Droge C, Keitel V, et al
    Bile Salt Export Pump-reactive Antibodies Form a Polyclonal, Multi-inhibitory Response in Antibody-induced BSEP Deficiency.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28311.
    PubMed     Text format     Abstract available


  814. HALAZUN KJ, Patzer RE, Rana AA, Samstein B, et al
    Reply: To PMID 24954365.
    Hepatology. 2015;62:1328-9.
    PubMed     Text format    


  815. YANG T, Lau WY, Huang B, Schwartz M, et al
    Transplantation for hepatocellular carcinoma: more haste, less speed?
    Hepatology. 2015;62:1327-8.
    PubMed     Text format    


  816. CLOSS EI
    Putative role of cationic amino acid transporter-3 in murine liver metabolism.
    Hepatology. 2015;62:1326-7.
    PubMed     Text format    


  817. GU Q, Cui Z
    Reply: To PMID 25130427.
    Hepatology. 2015;62:1327.
    PubMed     Text format    


  818. DALY AK, Day CP, Liu YL, Anstee QM, et al
    TM6SF2 as a genetic risk factor for fibrosis.
    Hepatology. 2015;62:1321.
    PubMed     Text format    


  819. SOOKOIAN S, Pirola CJ
    Reply: To PMID 25302781.
    Hepatology. 2015;62:1321-2.
    PubMed     Text format    


  820. VERMA M, Navarro V
    Patient-centered care: a new paradigm for chronic liver disease.
    Hepatology. 2015;62:988-90.
    PubMed     Text format    


  821. LEE YK, Jee BA, Kwon SM, Yoon YS, et al
    Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression.
    Hepatology. 2015;62:1174-89.
    PubMed     Text format     Abstract available


  822. TOROK NJ
    Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?
    Hepatology. 2015;62:1313-5.
    PubMed     Text format    


  823. GUO W, Qiu Z, Wang Z, Wang Q, et al
    MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.
    Hepatology. 2015;62:1132-44.
    PubMed     Text format     Abstract available


  824. CHANG B, Xu MJ, Zhou Z, Cai Y, et al
    Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1.
    Hepatology. 2015;62:1070-85.
    PubMed     Text format     Abstract available


  825. PETTA S, Maida M, Macaluso FS, Di Marco V, et al
    The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease.
    Hepatology. 2015;62:1101-10.
    PubMed     Text format     Abstract available


  826. LAI M
    Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?
    Hepatology. 2015;62:997-8.
    PubMed     Text format    


    September 2015
  827. ZHOU M, Marc Learned R, Rossi SJ, DePaoli AM, et al
    Engineered FGF19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28257.
    PubMed     Text format     Abstract available


  828. PONSIOEN CY, Chapman RW, Chazouilleres O, Hirschfield GM, et al
    Surrogate endpoints for clinical trials in primary sclerosing cholangitis; review and results from an International PSC Study Group consensus process.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28256.
    PubMed     Text format     Abstract available


  829. KIM SH, Saide K, Farrell J, Faulkner L, et al
    Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.
    Hepatology. 2015;62:887-99.
    PubMed     Text format     Abstract available


  830. ZHOU JN, Zeng Q, Wang HY, Zhang B, et al
    MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Hepatology. 2015;62:801-15.
    PubMed     Text format     Abstract available


  831. REIG M, Bruix J
    Pattern of tumor progression in liver cancer: The missing partner in trial design.
    Hepatology. 2015;62:674-6.
    PubMed     Text format    


  832. VANWAGNER LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, et al
    Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.
    Hepatology. 2015;62:773-83.
    PubMed     Text format     Abstract available


  833. BUTLER NS, Schmidt NW
    Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis.
    Hepatology. 2015;62:680-3.
    PubMed     Text format    


  834. NAULT JC, Rebouissou S, Zucman Rossi J
    NRF2/KEAP1 and Wnt/beta-catenin in the multistep process of liver carcinogenesis in humans and rats.
    Hepatology. 2015;62:677-9.
    PubMed     Text format    


  835. HOKI T, Miyanishi K, Tanaka S, Takada K, et al
    Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis.
    Hepatology. 2015;62:751-61.
    PubMed     Text format     Abstract available


  836. MARZANO C, Cazals-Hatem D, Rautou PE, Valla DC, et al
    The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome.
    Hepatology. 2015;62:956-63.
    PubMed     Text format     Abstract available


    August 2015
  837. TRIVEDI PJ, Corpechot C, Pares A, Hirschfield GM, et al
    Risk Stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists.
    Hepatology. 2015 Aug 20. doi: 10.1002/hep.28128.
    PubMed     Text format     Abstract available


    July 2015
  838. HENRY ZH, Northup PG
    Baclofen for the treatment of muscle cramps in patients with cirrhosis: A new alternative.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27988.
    PubMed     Text format     Abstract available


    June 2015
  839. CHIANG JY
    Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27964.
    PubMed     Text format    


  840. CARULLI L, Gabbi C, Bertolotti M
    Bile acids and non-alcoholic fatty liver disease: An intriguing relationship.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27963.
    PubMed     Text format    


  841. BARBIER-TORRES L, Beraza N, Fernandez-Tussy P, Lopitz-Otsoa F, et al
    Histone Deacetylase 4 promotes cholestatic liver injury in the absence of Prohibitin-1.
    Hepatology. 2015 Jun 25. doi: 10.1002/hep.27959.
    PubMed     Text format     Abstract available


    May 2015
  842. KUMAR S
    Cholestatic Liver Injury secondary to Artemisinin.
    Hepatology. 2015 May 16. doi: 10.1002/hep.27900.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: